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Abstract
This study investigated the utility of the Personality Assessment Inventory (PAI)
for diagnosing and discriminating between Major Depressive Disorder (MDD) and
Generalized Anxiety Disorder (GAD) with university counseling center clients.
Participants were 1541 male and female students who received services at a student
counseling center at a large university. Participants were classified as MDD, GAD, or
Other Diagnosis (OD) based on the diagnosis determined by the treating clinician, and
PAI profiles were compared between the three groups.
The PAI Structural Summary-Revised contains Diagnostic Consider Clusters
(DCC) that were designed to identify PAI scales/subscales that are typically elevated or
suppressed when a particular disorder is present. The DCC’s for MDD and GAD were
examined and the results demonstrated that the criteria for the DCC for MDD were met
by 2.2% of the MDD group, and the criteria for the DCC for GAD were met by 3.8% of
the GAD group. A discussion of these findings is offered, and the appropriateness of
using the DCC’s for the purpose of diagnosis with any population is questioned.
Additionally, DCC’s for MDD and GAD for use with university counseling center clients
are proposed.
Finally, discriminant analysis (DA) was employed to develop various
discriminant functions that can be used to classify individual PAI profile data into
specific diagnostic groups. In particular, one discriminant function was created that is
capable of examining any PAI profile, and classifying it as either MDD or OD. A second
vi

discriminant function was produced that can analyze any PAI profile and categorize it as
either GAD or OD. The final discriminant function was developed to evaluate a PAI
profile that represents either MDD or GAD and determine which diagnosis is appropriate.
Each discriminant function was shown to accurately predict the associated diagnoses. A
discussion of the various predictor variables is offered. Taken together, these results
support the use of the PAI for diagnosing and discriminating between MDD and GAD
with university counseling center clients.
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CHAPTER I: INTRODUCTION
Statement of the Problem
As defined by the text revision of the fourth edition of the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV: Text Revision; American Psychiatric
Association, 2000), Major Depressive Disorder (MDD) and Generalized Anxiety
Disorder (GAD) represent two of the most commonly occurring psychological disorders
(see Appendix A and Appendix B for the respective diagnostic criteria for MDD and
GAD). Additionally, data collected during a recent 40-month period at a large university
counseling center showed that MDD and GAD were the two most frequently diagnosed
disorders. In the 2009 Pilot Study (Locke, 2009) from the Center for the Study of
Collegiate Mental Health (CSCMH), data was collected using a standardized data set in
the fall semester of 2008 from over 28 thousand students who received mental health
services at 66 college and university counseling centers. These data demonstrated that the
same types of clients and problems tend to be seen by all counseling centers regardless of
their parent institution (Locke, 2009). Together, these findings suggest that MDD and
GAD are the two psychological disorders most generally treated at university counseling
centers.
In addition to the high prevalence rates, the symptoms of MDD and GAD cause
clinically significant distress or impairment in one or more important areas of functioning
(DSM-IV: TR; APA, 2000). In fact, the CSCMH study found that level of academic
distress was most strongly related to symptoms of depression and generalized anxiety
1

(Locke, 2009). Due to the frequency of these disorders among university counseling
center clients and the significant impact they have on an individual’s well-being, it is
important that each disorder be accurately identified and treated appropriately.
One aspect of this process requires discriminating between MDD and GAD when
developing a diagnosis and this process can be complicated by certain issues. In
particular, concerns exist regarding the somatic symptoms of GAD in that they almost
entirely overlap with those of major depression (Roemer, Orsillo & Barlow, 2002). In
fact, Brown, Marten, and Barlow (1995) found that the associated symptom criterion for
GAD in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV; American Psychiatric Association, 1994) did not significantly discriminate
patients with GAD from those with MDD or Dysthymic Disorder. Therefore, in addition
to the aforementioned concerns these disorders represent in university counseling centers,
difficulties exist in creating accurate differential diagnosis of the disorders.
Throughout the process of psychodiagnostic assessment, psychologists frequently
form and test clinical hypotheses based upon data collected from psychological
assessment instruments (Spengler, Strohmer, Dixon, & Shivy, 1995). The Personality
Assessment Inventory (PAI; Morey, 1991) has become one of the more commonly used
tests for measuring psychopathology and psychological functioning (Belter & Piotrowski,
2001; Boccaccini & Brodsky, 1999; Piotrowski & Belter, 1999). The PAI contains 344
items that comprise 22 non-overlapping scales including 4 validity scales, 11 clinical
scales, 5 treatment scales, and 2 interpersonal scales (Morey, 1991). Appendix C contains
2

a description of the PAI clinical, treatment, and interpersonal scales. Kurtz and Blais
(2007) note that additional research should be conducted to determine the validity and
utility of using personality measures like the PAI to aid in psychodiagnosis.
In his development of the PAI Structural Summary-Revised, Morey (2007a)
created diagnostic consideration clusters (DCC) that are based on both the content of the
PAI scales (Morey, 1991) and on the results of studies that have examined specific
diagnostic groups for typical scale elevations and suppressions (Morey & Hopwood,
2007). The DCC’s were designed to identify PAI scales/subscales that are typically
elevated or suppressed when a particular disorder is present. See Appendix D for a
description of the DCC’s for MDD and GAD. In addition to using the respective DCC to
aid in the diagnosis of MDD and GAD, Morey and Hopwood (2007) suggest that the
DCC’s can be useful for differential diagnosis.
The DCC’s for GAD and MDD were determined based on trends in the
standardization samples used in development of the PAI (Morey, 1996). Three different
samples were used when standardizing the PAI and included a community sample,
patients from various clinical settings, and college students from several universities
(Morey, 1991). Green, Lowry, and Kopta (2003) demonstrated significant differences in
college students and college counseling center clients including level of well-being, life
functioning, and global mental health. They found that adults not in treatment were the
healthiest, followed in decreasing order by college students, college counseling center
clients, and adult outpatients. These findings suggest that the DCC’s recommended by
3

Morey (2007a) are not necessarily generalizable to university counseling center clients.
Furthermore, Morey (1996) suggested that cross-validational research be conducted on
the DCC’s since they are based on the standardization samples of the PAI.
To date, no studies have examined the validity of the PAI’s DCC’s for MDD and
GAD. Furthermore, the extant literature does not provide information regarding PAI
scales/subscales that discriminate between a diagnosis of MDD and GAD. This study
aims to address these gaps in the literature. The purpose of this study is four-fold: (1) To
investigate the validity of the PAI’s DCC’s for MDD and GAD with university
counseling center clients, (2) To determine which, if any, scales or subscales of the PAI
discriminate between a diagnosis of MDD and GAD in university counseling center
clients, (3) To contribute to the growing literature on the use of the PAI as a diagnostic
tool, and (4) to provide information to university counseling center professionals that
facilitates the diagnosis and treatment of clients who present with MDD or GAD.
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CHAPTER II: LITERATURE REVIEW
Major Depressive Disorder
Major Depressive Disorder (MDD) (APA, 2000) is a frequently occurring
psychological disorder that causes varying levels of clinically significant distress (see
Appendix A for the diagnostic criteria for MDD). Estimates of community samples have
reported lifetime risk for MDD of 10% to 25% for women and 5% to 12% for men. The
prevalence rates for MDD do not appear to be related to ethnicity, education, income, or
marital status (APA, 2000). MDD has been shown to have significant biological/genetic
components, and studies have demonstrated that it is 1.5 to 3.0 times as common among
first-degree relatives of individuals with the disorder compared to the general population
(APA, 2000). The most negative outcome of MDD is suicide, which is estimated to occur
in as many as 15% of individuals who have the severe form of the disorder (APA, 2000).
The course of MDD is characterized by one or more Major Depressive Episodes.
The rate of recurrence is widely variable, and some individuals will have isolated
episodes that are several years apart, while others experience progressively more frequent
episodes as they age (APA, 2000). Studies have shown that with each additional episode
that occurs, the risk for future episodes is increased to the degree that having three
episodes leads to a 90% chance of having a fourth (APA, 2000). Episodes are often
preceded by a major psychosocial stressor, and studies have suggested that these stressors
may have a more significant impact on the first or second episodes, and less of an
influence on subsequent episodes (APA, 2000).
5

Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD) (APA, 2000) is a commonly occurring
psychological disorder that is characterized by excessive anxiety and worry that cause
clinically significant distress (see Appendix B for the diagnostic criteria for GAD).
Estimates of community samples have reported the lifetime prevalence rate to be 5%
(APA, 2000). GAD has been shown to have significant biological/genetic components. In
particular, the genetic factors that appear to play a role in the risk for GAD may be
intimately connected to those for MDD (APA, 2000).
The course of GAD is chronic and variable with stressful times often worsening
the disorder (APA, 2000). Several individuals diagnosed with GAD report that they have
experienced nervousness and anxiety their entire life (APA, 2000). More than half of
those who seek treatment for GAD report onset in childhood or adolescence, although it
is not uncommon for onset to occur after age twenty (APA, 2000).
Differential Diagnosis of MDD and GAD
Both MDD and GAD frequently co-occur with several other psychiatric disorders,
and in particular, the two often co-exist (APA, 2000). Additionally, the associated
symptom criteria for MDD and GAD have significant overlap, which complicates
differential diagnosis of the two disorders. In particular, four of the six physical symptom
criteria of GAD – restlessness, fatigue, difficulty concentrating, and sleep disturbance –
are also part of the diagnostic criteria for MDD (APA, 2000). Indeed, Brown et al. (1995)
found that the physical symptom criteria for GAD in the DSM-IV (APA, 1994) did not
6

significantly discriminate patients with GAD from those with MDD or Dysthymic
Disorder. Despite the diagnostic symptom overlap, studies have found differences in the
physical presentation of MDD and GAD. For instance, Joorman and Stoeber (1999)
found that difficulty concentrating was more powerfully linked to depressive symptoms
than to worry. Additionally, Aldao, Mennin, Linardtos, and Fresco (2010) demonstrated
that muscle tension was experienced to a greater degree in GAD than MDD.
MDD and GAD also have cognitive symptom criteria that overlap; however,
recent studies have revealed that there are certain aspects of cognition that appear to
manifest differently in MDD and GAD. In particular, intolerance of uncertainty, a
measure of the degree to which an individual believes that uncertainty is not acceptable,
has been shown to have greater elevations in GAD compared to MDD (Dugas, Buhr, &
Ladouceur, 2004; Dugas, Schwartz, & Francis, 2004).
Affective experience is another realm that has been studied in MDD and GAD.
Again, although there are emotional symptoms that overlap in the two disorders, studies
have uncovered differences in particular aspects of emotional expression between MDD
and GAD. Specifically, the construct of emotion intensity, which is defined to be the
subjective strength of an emotional response, has demonstrated elevated levels in GAD
(Mennin, Heimberg, Turk, & Fresco, 2005). Furthermore, more recent research has found
emotion intensity to be greater in GAD than Depressive disorders (Kerns, Aldao, &
Mennin, 2008; Mennin, Holoway, Fresco, Moore, & Heimberg, 2007).
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Another characteristic of emotional expression that has shown differences of
expression in MDD and GAD is the construct of positive affect, which is conceptualized
as a measure of the extent to which a person feels enthusiastic, active, and alert.
Consequently, low positive affect is manifested as decreased arousal, activity, and energy
(Beck et al., 2001). Aldao et al. (2010) found that reduced positive affect was associated
with MDD, while individuals with a diagnosis of GAD demonstrated normal levels of
positive affect.
Diagnostic Consideration Clusters
The PAI Structural Summary-Revised (Morey, 2007a) was created to provide
clinicians with a means of integrating information from a PAI protocol that could be used
to facilitate the process of interpretation and case formulation (Morey & Hopwood,
2007). The Structural Summary-Revised is comprised of four sections including: (1)
Profile Distortion Analysis, (2) Diagnostic Consideration Clusters, (3) Self/Other Issue
Clusters, and (4) Differential Treatment Indicators (Morey, 2007a). Of particular interest
to the present study is the second section, Diagnostic Consideration Clusters (DCC).
The DCC’s are intended to serve the clinician by guiding them in the formation
and testing of diagnostic hypotheses (Morey & Hopwood, 2007). The Structural
Summary-Revised contains DCC’s for 33 specific disorders that correspond with DSMIV-TR diagnoses (APA, 2000). The DCC’s are separated into the following seven
categories: (1) Affective Disorders, (2) Anxiety Disorders, (3) Psychotic Disorders, (4)
Somatoform Disorders, (5) Personality Disorders, (6) Substance Abuse Disorders, and (7)
8

Other Diagnoses (Morey, 2007a). The range of disorders covered by the DCC’s includes
“No Diagnosis” and Dissociative Identity Disorder (Morey, 2007a). In addition to using
the DCC’s to determine the presence of specific disorders, Morey and Hopwood (2007)
suggest that the DCC’s can be useful for differential diagnosis.
Each DCC contains a cluster of scales/subscales that are typically elevated or
suppressed in the presence of a particular diagnosis (Morey & Hopwood, 2007).
Importantly, the determination of elevation and suppression is made within the context of
the profile rather than simply being based on a particular cutoff score. Morey and
Hopwood (2007) suggest using the Mean Clinical Elevation (MCE) as a reference point
for making this determination. The MCE is the average T score from all 11 clinical
scales; therefore, if a profile has a MCE of 70T, then a scale/subscale score of 60T would
be considered a relative suppression despite the fact that it is elevated relative to the
community norms of the PAI scales/subscales, which are represented by 50T (Morey,
1991). The selection of scales/subscales for the DCC’s was based on the constructs that
individual scales/subscales were designed to measure (Morey, 1991), and on the results
of studies that have examined specific diagnostic groups for typical scale/subscale
elevations (Morey & Hopwood, 2007). Of particular interest in the present study are the
DCC’s for MDD and GAD.
The DCC’s for GAD and MDD were determined based on trends in the
standardization samples used in the development of the PAI (Morey, 1996). Three
different samples were used when standardizing the PAI and included a community
9

sample, patients from various clinical settings, and college students from several
universities (Morey, 1991). Appendix D contains a description of the DCC’s for MDD
and GAD, including which scales/subscales are expected to be elevated or suppressed.
Morey and Hopwood (2007) propose that individuals with a diagnosis of MDD
will typically demonstrate elevations of all three DEP subscales and the SUI scale.
Additionally, the authors note that the presence of low self-esteem (MAN-G), social
withdrawal (SCZ-S) and cognitive inefficiency (SCZ-T), which are often seen in MDD,
will significantly impact these subscales. Consequently, the DCC for MDD contains
DEP-A, DEP-P, DEP-C, SUI, SCZ-T, and SCZ-S as relative elevations, and MAN-G as a
relative suppression.
Morey (2003) suggests that an elevation on the ANX-A subscale, without
corresponding elevations on the other two ANX subscales, is suggestive of generalized
anxiety as opposed to more specific worries such as obsessive thoughts, phobias, or
preoccupation with somatic concerns. Accordingly, the DCC for GAD includes the
ANX-A subscale as a relative elevation, but does not contain the other two ANX
subscales. Furthermore, Morey and Hopwood (2007) suggest that an elevation on ANX
in the absence of elevations on ARD and DEP is indicative of a diagnosis of GAD.
Again, this is consistent with the DCC for GAD which contains ANX as a relative
elevation and ARD as a relative suppression.
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CHAPTER III: MATERIALS AND METHODS
Overview
An archival data set from a counseling center at a large southeastern university
was used to obtain the data for this study. Specifically, these data were collected during
the period of October 2005 to June 2009 from university students who were receiving
psychological services at the counseling center. Prior to inclusion in the research archive,
each client consented to have their non-identifying data archived for future research. As
an archival study, this study was approved by the university’s Institutional Review Board
(IRB).
Counseling Center Description
The counseling center provides undergraduate and graduate students of the
university with free individual, couples, and group therapy. Students initially come to the
center during walk-in hours and complete a packet of information that includes
demographic information, current symptoms and concerns, available times for therapy,
and information regarding confidentiality and the therapy process. The paperwork
contains an informed consent form regarding the archival of their de-identified data for
research purposes. Clients who consent to the inclusion of their records in the archival
data set are assigned a research identification number that helps to ensure their anonymity
and confidentiality, while still allowing for future matching of various forms of client
data. Students complete the PAI between intake and their first session of therapy. PAI’s
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that were either incomplete or completed incorrectly were excluded from use in this
study.
The therapists at the counseling center include 10 licensed psychologists, 4 predoctoral psychology interns, and 3 graduate assistants and 5 to 16 practicum students who
are doctoral students in counseling or clinical Psychology. Each of the therapists has been
trained in generating accurate differential diagnoses. Additionally, for those therapists
who are still in training, a licensed psychologist supervises their work and reviews the
diagnoses they generate to ensure their accuracy and thoroughness. Following the first
and fifth sessions of therapy, and again when therapy is terminated, therapists make a
full, five-axis DSM-IV-TR (APA, 2000) diagnosis.
Participants
Participants were 1541 students who received services at the student counseling
center at a large southeastern university during the period of October 2005 to June 2009.
The mean age of the sample was 22.42 (SD = 5.15; range 18 - 59), and included 1052
females (68.5%) and 483 males (31.5%). Six participants did not report their gender.
There were 683 participants (44.3%) who either did not report their race/ethnicity, or the
information had not been recorded. Self-identified racial/ethnic data were available for
858 participants (55.7%) and included 722 (84.1%) White/Caucasian/European
American, 71 (8.3%) African American/Black, 25 (2.9%) Asian/Asian American, 13
(1.5%) Other, 11 (1.3%) Hispanic/Latino/a, 8 (0.9%) Multiracial, 5 (0.6%) Arab
American, 2 (0.2%) American Indian/Alaskan Native, and 1 (0.1%) East Indian.
12

The sample used in this study is very similar with respect to age and gender, but
somewhat dissimilar in racial/ethnic configuration, to the population in the 2009 CSCMH
pilot study (Locke, 2009) which had a mean age of 22.7 (SD = 5.38; range 18 – 80), a
composition of 64.3% females and 35.4% males, and racial/ethnic configuration of
70.4% White/Caucasian/European American, 7.7% African American/Black, 6.2%
Asian/Asian American, 2.5% Other, 5.8% Hispanic/Latino/a, 3.2% Multiracial, 0.5%
Arab American, 0.4% American Indian/Alaskan Native, 0.6% East Indian, 0.3% Native
Hawaiian or Pacific Islander, and 2.4% who preferred not to answer.
Participants were separated into three categories: (1) those who had received a
diagnosis of MDD with no co-morbid Axis I disorder (n = 135), (2) those who had
received a diagnosis of GAD with no co-morbid Axis I disorder (n = 79), and (3) those
who had received any diagnosis other than the two just described, which could include a
diagnosis of MDD and/or GAD with one or more co-morbid Axis I disorder(s) (n =
1327). The three categories described above will be referred to hereafter as MDD, GAD,
and OD (Other Diagnosis) respectively.
The choice to restrict participants diagnosed with co-morbid Axis I disorders from
the MDD and GAD categories was based upon the belief that the presence of additional
Axis I disorders would significantly impact the profile configuration on the PAI. This
assumption was based on both the conceptual design of the PAI clinical scales (Morey,
1991) and the findings from previous studies. In particular, Drury et al. (2009) found
significant differences in PAI clinical profile elevation when they compared women with
13

a single Axis I diagnosis of posttraumatic stress disorder (PTSD) to women diagnosed
with PTSD and one or more additional Axis I disorders. The authors concluded that the
clinical profile elevation of the PAI is clearly impacted by the co-morbidity of psychiatric
illnesses. Therefore, in an attempt to create the most representative PAI profiles for MDD
and GAD, this study placed participants with co-morbid Axis I disorders in the OD
category.
Instrument
The PAI is a self-administered, objective inventory of adult personality that
provides information on important clinical variables (Morey, 1991). It contains 344 items
that consist of 22 non-overlapping full scales. Additionally, 10 of the full scales contain 3
or 4 subscales that are conceptually derived to cover the full breadth of their
corresponding complex clinical constructs. The full scales are grouped into the following
four categories: validity, clinical, treatment, and interpersonal. The four validity scales
include Inconsistency (ICN), Infrequency (INF), Negative Impression (NIM), and
Positive Impression (PIM). See Appendix C for a description of the clinical, treatment,
and interpersonal scales/subscales. The scale/subscale raw scores are transformed into T
scores to allow for interpretation relative to the standardization sample of 1000
community-dwelling adults. Each scale/subscale has a mean of 50T and a standard
deviation of 10T. A scale/subscale score of 70T, two standard deviations above the mean,
represents a significant deviation from the typical adult living in the community given
that approximately 98% of nonclinical subjects will have scores below this value. As
14

such, Morey (1991) suggests that scale/subscale scores of 70T or higher represent
clinically significant problem areas. To view examples of PAI profiles, go to Appendix E
which contains separate graphs for the full scales and subscales, including horizontal
lines at 50T and 70T to represent the mean and clinically significant levels respectively.
The PAI was developed based upon a construct validation framework that utilized
both rational and empirical approaches to scale development. This method strongly
emphasizes scale stability and correlates, and places importance on the use of both
theoretical and quantitative items. Morey (1991) found the internal consistency reliability
of the PAI full scales to have median coefficient alphas of .81, .86, and .82 for the
normative, clinical, and college samples respectively. Additionally, the mean interitem
correlations for the full scales were .22, .29, and .21 for the three respective samples. The
mean test-retest reliability for the full scales of the various PAI samples ranged from .75
to .79. The PAI has been well validated for several treatment populations (Morey,
2007b), and various PAI scales have correlated well with scales of several other
frequently used personality and diagnostic instruments that measure similar constructs
(Morey, 1991).
Procedure
For the purposes of this study, the fifth session diagnosis was determined to be the
most appropriate based on a number of considerations. First, given that the PAI is
administered prior to the first session of therapy, it is important to use a diagnosis that is
temporally close to that date due to the possibility of symptom change over time. Second,
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under the supposition that additional client contact yields increased diagnostic accuracy,
the diagnosis following the fifth session should be more precise than one following the
first session. For those clients who attended less than five sessions, their diagnosis
following termination was used based upon the same reasoning noted above. Diagnostic
qualifiers were taken into consideration and only diagnoses without a qualifier or with a
“principle” qualifier were selected for the MDD and GAD groups. Diagnoses with
qualifiers of “provisional”, “traits”, or “rule out” were not placed in the MDD or GAD
groups given the uncertainty of the diagnosis. Additionally, diagnoses of MDD with no
co-morbid Axis I disorder that had a specifier of either partial or full remission were not
included in the MDD group. It is possible that the therapist’s diagnostic decisions were
influenced by reviewing the results of the PAI prior to making their diagnosis. Although
the PAI results do provide interpretive hypotheses regarding diagnosis, they are merely
suggestions, and the clinician is still expected to consider all possible diagnoses that are
applicable to a given client.
Titanium Schedule was used to generate a report that contained diagnostic and
demographic information for clients who had consented to the inclusion of their records
in the archival data set. The report also provided the research identification numbers that
were then used to match diagnostic and demographic information with PAI data that were
only identifiable by the associated research identification numbers. These data were
entered into an SPSS file and analyzed as described below.
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Analyses
Data analysis began by assessing the validity of each participant’s PAI profile,
which was determined using the following cutoff scores suggested by Morey (1991) for
the four validity scales: ICN >= 73T, INF >= 75T, NIM >= 92T, and PIM >= 68T. Every
PAI profile that exceeded one or more of these scale scores was considered invalid. This
process led to the removal of 79 participants from the study including eight from the
MDD group, four from the GAD group, and 67 from the OD group.
The remaining data were then used to calculate mean PAI profiles for the entire
sample, the MDD group, the GAD group, and the OD group. Next, the mean clinical
elevation (MCE) was computed for each participant using the method described by
Morey and Hopwood (2007), which entails summing the T scores of the 11 clinical scales
and then dividing the sum by 11. The MCE for each participant was used to calculate a
mean MCE for the entire sample, the MDD group, and the GAD group. Each
participant’s MCE was then used to evaluate their scores on the scales/subscales of the
DCC’s for MDD and GAD (Morey, 2007a). As suggested by Morey (2007b), a
scale/subscale was determined to be relatively elevated or suppressed if it had a T score
that was more than 5 above or below the MCE, respectively. These results were then used
to compute the percentage of participants in each of the three diagnostic groups (MDD,
GAD, and OD) that exhibited the relative elevations and suppressions of the DCC’s for
MDD and GAD.

17

Data analysis concluded by performing three discriminant analyses (DA) to
determine the linear combination of scales/subscales of the PAI which most accurately
discriminated between each pair of the three diagnostic groups: (1) MDD from OD, (2)
GAD from OD, and (3) MDD from GAD. DA is useful for several purposes including,
examining differences between groups, determining the most parsimonious way to
distinguish between groups by discarding variables that are not very useful for the task,
and classifying individual cases into groups using a discriminant prediction equation. The
current study used DA to create discriminant functions capable of predicting between two
diagnostic groups with the aim of incorporating as few scales/subscales as possible.
To achieve the above mentioned goal, the decision was made to use the stepwise
method of DA given the nature of the data. Specifically, 9 of the 11 clinical scales and 1
of the 5 treatment scales of the PAI are comprised of 3 subscales (with the exception of
the BOR scale which contains 4 subscales). Each of these 10 full scales is calculated by
summing the raw scores of the respective subscales, and then converting the result into an
appropriate T score (Morey, 1991). As such, there are high levels of correlation between
these full scales and each of their subscales. Additionally, many (although not all)
subscales are highly correlated with the other subscales associated with the same full
scale (e.g., DEP-C and DEP-A). This is due to the fact that they measure specific
constructs within the same general construct domain (Morey, 1991). Given the
multicollinearity of the data, it was determined that it would be most appropriate to use
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the stepwise method of DA to achieve the goal of fewest scales/subscales being used in
the discriminant functions.
The stepwise procedure works by first selecting the most highly correlated
independent variable (in the case of this study, a PAI scale/subscale), removing the
variance in the dependent variable (in the case of this study, diagnosis), then selecting the
independent variable (another PAI scale/subscale) that is most highly correlated with the
remaining variance in the dependent variable. This process continues until the addition of
another independent variable does not increase the canonical R-squared value by a
significant amount (.05 was established as the significance level in this study). Thus, an
independent variable that is highly correlated with one that has already been selected is
unlikely to be added due to the lack of additional discriminatory power. This impacts the
current study in that the resultant discriminant function is unlikely to contain multiple
scales/subscales from the same domain (e.g., DEP and DEP-P). Although a particular
domain may, and often does, contain two or more scales/subscales with significantly
different mean T scores between the two diagnostic groups being considered, only the
scale/subscale that provides the greatest differentiation between groups is likely to be
selected. Therefore, the stepwise procedure facilitates the creation of the most
parsimonious discriminant function, which was the goal in the present study.
Hypotheses
It was hypothesized that the results of this study would confirm the validity of the
DCC’s for MDD and GAD with university counseling center clients. Furthermore, based
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on the DCC for MDD (Morey, 2007a) and the mean PAI profile for MDD (Morey, 1991),
it was hypothesized that the following scales and subscale would be found to discriminate
between the MDD and OD diagnostic groups: (1) DEP, (2) SUI, and (3) MAN-G. Morey
(1991) does not provide a mean PAI profile for GAD; however, he suggests that an
elevation on the ANX-A subscale, without corresponding elevations on the other two
ANX subscales, is suggestive of generalized anxiety as opposed to more specific worries
such as obsessive thoughts, phobias, or preoccupation with somatic concerns (Morey,
2003). Thus, based on the DCC for GAD (Morey, 2007a) and the recommended use of
the ANX subscales to identify general forms of anxiety (Morey, 2003), it was
hypothesized that (1) the ANX-A subscale and (2) the SCZ full scale would be found to
discriminate between the GAD and OD diagnostic groups. Finally, based on the DCC’s
for MDD and GAD (Morey, 2007a), the mean PAI profile for MDD (Morey, 1991), and
the aforementioned use of the ANX subscales (Morey, 2003), it was hypothesized that
the following scale/subscales would be capable of discriminating between the MDD and
GAD diagnostic groups: (1) DEP-A, (2) ANX-A, (3) SUI, (4) MAN-G, (5) SCZ-S, and
(6) SCZ-T.

20

CHAPTER IV: RESULTS
PAI Profiles
Various graphs of the mean PAI full scale and subscale elevations for MDD,
GAD, OD, and the entire sample can be found in Appendix E. The available graphs
include: (1) separate graphs (full scale and subscale) for the entire sample, (2) separate
graphs for MDD, including representations of the mean MCE and its elevation and
suppression boundaries, (3) separate graphs for GAD, including representations of the
mean MCE and its elevation and suppression boundaries, (4) graphs comparing MDD,
GAD, and the entire sample, (5) graphs comparing MDD and OD, (6) graphs comparing
GAD and OD, and (7) graphs comparing MDD and GAD. Appendix F contains
numerical values for the means and standard deviations of the PAI full scale and subscale
T scores for MDD, GAD, OD, and the entire sample.
Mean Clinical Elevations
The mean MCE for the entire sample was 56.36T (SD = 7.67; range 32.91 –
84.82; N = 1541). The mean MCE for the MDD group was 57.60T (SD = 6.12; range
46.45 – 74.82; n = 135). Finally, the mean MCE for the GAD group was 55.54T (SD =
6.06; range 42.25 – 78.91; n = 79).
Diagnostic Consideration Clusters
Calculations were performed to determine the percentage of participants in each
of the three diagnostic groups (MDD, GAD, and OD) that matched every scale/subscale
elevation and suppression for the MDD and GAD DCC’s. Post-hoc analyses were
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conducted to find the percentage of participants in each of the three diagnostic groups
that matched each individual scale/subscale elevation and suppression for the MDD and
GAD DCC’s. The results of these calculations can be found in Appendix G.
Discriminant Analyses
DA’s were performed on all pairs of the three diagnostic groups: (1) MDD and
OD, (2) GAD and OD, and (3) MDD and GAD. For reasons previously explained, the
stepwise method of DA was used. When the stepwise procedure is employed, it is
recommended that cross-validation be utilized to confirm the results of the DA. Each of
the three DA’s were cross-validated using the jack-knife procedure. In each case, the
results of the cross-validation procedure confirmed the appropriateness and accuracy of
the stepwise procedure.
The first DA was conducted to determine which PAI scales/subscales
discriminated between a diagnosis of MDD and OD. The overall Wilks’ Lambda was
significant, Λ = .907, χ2 (4, n = 1462) = 141.76, p < .001, indicating that the discriminant
function differentiated between the two diagnostic groups. The canonical correlation was
.304, which reveals that 9.2% of the variation between the two diagnostic groups was
discriminated by the selected scales/subscales. Diagnostic category was predicted using
four PAI scales/subscales, listed in decreasing order of significance: (1) DEP, (2) ANX,
(3) SUI, and (4) ANT-E. Pooled within-groups correlations between the predictors and
the discriminant function, and the standardized discriminant function coefficient for each
predictor are presented together in Appendix H. When attempting to predict group
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membership, classification was successful in 68.1% of the MDD group, and 74.0% of the
OD group. Of the original grouped cases, 73.5% were correctly classified.
Next, a DA was run to determine which PAI scales/subscales discriminated
between a diagnosis of GAD and OD. The overall Wilks’ Lambda was significant, Λ =
.899, χ2 (3, n = 1406) = 149.41, p < .001, indicating that the discriminant function
differentiated between the two diagnostic groups. The canonical correlation was .318,
which reveals that 10.1% of the variation between the two diagnostic groups was
discriminated by the selected scales/subscales. Diagnostic category was predicted using
three PAI subscales, listed in decreasing order of significance: (1) ANX-C, (2) BOR-I,
and (3) DEP-A. Pooled within-groups correlations between the predictors and the
discriminant function, and the standardized discriminant function coefficient for each
predictor are presented together in Appendix I. When attempting to predict group
membership, classification was successful in 82.3% of the GAD group, and 77.2% of the
OD group. Of the original grouped cases, 77.5% were correctly classified.
Finally, a DA was performed to determine which PAI scales/subscales
discriminated between a diagnosis of MDD and GAD. The overall Wilks’ Lambda was
significant, Λ = .412, χ2 (6, n = 214) = 185.55, p < .001, indicating that the discriminant
function differentiated between the two diagnostic groups. The canonical correlation was
.767, which reveals that 58.8% of the variation between the two diagnostic groups was
discriminated by the selected scales/subscales. Diagnostic category was predicted using
six PAI scales/subscales, listed in decreasing order of significance: (1) ANX, (2) DEP-A,
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(3) BOR-S, (4) SCZ-P, (5) SOM-S, and (6) MAN-G. Pooled within-groups correlations
between the predictors and the discriminant function, and the standardized discriminant
function coefficient for each predictor are presented together in Appendix J. When
attempting to predict group membership, classification was successful in 93.3% of the
MDD group, and 89.9% of the GAD group. Of the original grouped cases, 92.1% were
correctly classified.
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CHAPTER V: DISCUSSION
Diagnostic Consideration Cluster for MDD
It was hypothesized that the DCC for MDD would be shown to be valid when
used with university counseling center clients. In stark contrast to this expectation, the
results indicated that only 2.2% of the participants in the MDD group demonstrated all of
the scale/subscale elevations and suppressions (see Appendix G for complete results of
the DCC analyses); therefore, I decided to examine each of the seven scales/subscales
individually. One possible reason for the extremely low hit rate was that one or more of
the scales/subscales were not valid. In such a scenario, it was possible for all of the other
scales/subscales to be valid, but since the initial computation required all seven to be
valid, having even one invalid scale/subscale would likely cause a “miss” for a large
majority of the group members, and thus account for the final result being lower than
anticipated.
Based upon the aforementioned possibility, I evaluated each scale/subscale
individually. The results showed that three subscales – DEP-A, DEP-C, MAN-G – had
hit rates greater than 70%, which suggests that they are reasonably valid for the purpose
of detecting the presence of MDD in university counseling center clients. The remaining
four scales/subscales – SCZ-S, SUI, DEP-P, SCZ-T – had hit rates between 37% and
57%. It could reasonably be argued that these four scales/subscales are not valid for use
in detecting the presence of MDD. Although the lowest individual scale/subscale hit rate
was still greater than one-third, the fact that more than half of the scales/subscales had hit
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rates near or below 50% likely accounts for the extremely low hit rate of 2.2% when
every scale/subscale in aggregate was required to meet criteria. Taken together, these
results indicate the DCC for MDD is not recommended for detecting the presence of
MDD with the population sampled in this study.
When the graphs containing the mean PAI full scale and subscale elevations for
the MDD group are examined in Appendix E, it is possible to visualize why the
preceding results were obtained. The graphs contain a solid yellow line that represents the
mean MCE for the MDD group, and two dashed yellow lines above and below the mean
MCE line that represent the boundaries for relative elevation and suppression. As shown
in the MDD subscale graph, the mean elevations for DEP-A and DEP-C are a
considerable distance above the cutoff for relative elevation. Accordingly, each subscale
demonstrated a hit rate in the 80% range. Similarly, the mean elevation for the MAN-G
subscale is a moderate distance below the relative suppression, and had a hit rate close to
70%. Three of the four remaining scales/subscales – SUI, DEP-P, SCZ-T – have mean
elevations that are only slightly above the cutoff for relative elevation and exhibit hit
rates near 50%. Finally, SCZ-S is actually below the cutoff for relative elevation and
showed a hit rate near 37%.
It is reasonable that a scale/subscale that is at or very near the relevant cutoff for
relative elevation or suppression would have a hit rate near 50%. Based on the
assumption that the T scores for each scale/subscale are normally distributed within a
specified group, it follows that a group with a mean scale/subscale elevation that is near
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the cutoff for its corresponding relative elevation or suppression would have half of the
group members above and half of them below the cutoff, and thus a near 50% hit rate.
Using the same reasoning, it is realistic to expect that a group with a mean scale/subscale
elevation that is less than the cutoff for its corresponding relative elevation or more than
the cutoff for its corresponding relative suppression would have a hit rate below 50%.
The hit rate of 48.1% for DEP-P was unexpected. It is important to keep in mind
that the hit rate is based on the MCE, and thus an extremely large MCE could account for
such a low hit rate; however, in the case of the MDD group, the mean MCE was 57.60T,
which is less than one standard deviation above the community norm of 50T. In fact, as
seen in Appendix F, the mean elevation on the DEP-P subscale for the MDD group was
63.60T, which is less than the level of clinical significance. The other two DEP subscales,
DEP-C and DEP-A, each had mean elevations that were clinically significant.
The DEP-P subscale measures constructs such as physical functioning, energy,
and activity, as well as level of sleep pattern disturbance (Morey, 1991). One possible
explanation for the current findings is that university counseling center clients experience
fewer physiological symptoms of MDD than cognitive and affective symptoms.
However, the results obtained here are consistent with those found by Morey (1991) in
his sample of MDD patients which also demonstrated clinically significant elevations for
DEP-C and DEP-A, but not for DEP-P (Regarding the comparisons to the MDD sample
used by Morey, it is interesting to note that the present study had a greater number of
participants with a diagnosis of MDD, although only slightly so (n = 135 versus n =
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126)). This suggests that university counseling center clients are similar to Morey’s
clinical populations in their presentation of MDD. More likely, the consistent results
regarding the DEP-P subscale indicate that either it does not accurately measure the
construct it is designed to assess, or patients diagnosed with MDD indicate more
cognitive and affective symptoms than physiological symptoms. Future research could
examine the DEP subscales with patients who exhibit more prominent physiological
symptoms of depression as a means of assessing the accuracy of the DEP-P scale.
The SCZ-T subscale had a hit rate of 56.3% and mean elevation of 66.12T for the
MDD group. SCZ-T is designed to measure thought processes that are marked by
confusion and difficulty concentrating (Morey, 1991). Interestingly, these are similar to
one of the cognitive symptoms of MDD (APA, 2000). As such, it is somewhat surprising
that the DEP-C subscale, which measures the cognitive aspects of depression, was
clinically significant and yet the SCZ-T scale was not. Perhaps one explanation for this
finding is that the given the intent of the SCZ-T subscale to measure particular aspects of
Schizophrenia, the degree to which MDD patients experience the symptoms measured by
SCZ-T is not as high as patients with Schizophrenia, and thus did not reach the level of
clinical significance. Similar to DEP-C, DEP-A, and DEP-P, the results obtained here for
SCZ-T are consistent with those found by Morey (1991) in his sample of MDD. This
provides additional evidence to suggest that university counseling center clients are
similar to Morey’s clinical populations in their presentation of MDD.
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Another surprising result was that SCZ-S had a hit rate of only 37.8% and a mean
elevation of 59.08T, which was less than 2T above the mean MCE for the MDD group.
SCZ-S is designed to measure social isolation and amount of interpersonal relationships
that could be described as close and warm (Morey, 1991). One possible explanation for
the current findings is that at the point university students with MDD typically present for
treatment they may not have begun to isolate themselves from their friends as a result of
being depressed. Anecdotal evidence has shown that often university counseling center
clients are experiencing their first episode of major depression, and are thus confused and
startled by what is occurring, which leads them to seek treatment earlier in the process.
Another potential reason for these findings is that the environment of a university is such
that students will typically be around several others throughout their day as they attend
classes, live in a dorm, eat meals, etc. From a clinical standpoint, students with MDD
may be deemed to be isolating themselves and feeling they do not have close
relationships, but the content of the items for SCZ-S may be such that university students
with MDD do not endorse these items as a result of their environment.
The fourth and final scale of the DCC for MDD that was determined to be invalid
for detecting MDD in university counseling center clients was the SUI scale which had a
hit rate of 45.2% and mean elevation of 64.20T. The results obtained here are in stark
contrast to those obtained by Morey (1991) in his sample of patients with MDD which
showed a mean elevation that was well above the cutoff for clinical significance. One
explanation for this difference is that 54.8% of the MDD sample Morey (1991) used was
29

receiving inpatient treatment. As such, it is reasonable to expect that the mean elevation
on the SUI scale would be higher in that sample than the one used for the current study.
In fact, Morey (1991) states that the significant proportion of inpatients in the MDD
sample likely increased the elevation on the SUI scale.
Another possible explanation for the current finding is that university counseling
center clients with MDD either do not express a clinically significant level of suicidal
ideation, or they experience suicidal ideation to a lesser degree than the general
population with MDD. This is unlikely given that the latest data from the American
Association of Suicidology shows suicide to be the third highest cause of death among
15-24 year-olds (McIntosh, 2010). Although the rate of suicide is slightly less for this age
group than all ages combined, 9.7 versus 11.5 per 100,000 in the population (McIntosh,
2010), this slight difference is unlikely to account for the results obtained in the present
study. Additionally, suicide is the second leading cause of death among 20-24 year-olds,
and the lifetime suicide rate peaks for this age group (Locke, 2009). Furthermore, the
2009 CSCMH pilot study (Locke, 2009) found that 25% of university counseling center
clients reported they had seriously considered suicide at some point in their life. One
implication of the current finding is that when examining the SUI scale for university
counseling center clients, clinicians should consider the possibility that the level of
suicidality is clinically significant even if it is below 70T.
As previously mentioned, Morey and Hopwood (2007) suggest that in addition to
using the DCC’s to detect the presence of certain psychological disorders, they can be
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useful for differential diagnosis. Based on this assumption, it was decided a priori to
examine the DCC for MDD using the GAD and OD groups, and compare these results
with those for the MDD group as a means of inspecting the validity of the authors’ claim.
Given the results of the analyses on the MDD group, these additional computations were
unnecessary in that it was not possible for the DCC for MDD to be valid for differential
diagnosis. Nevertheless, the results of the analyses with the GAD and OD groups
revealed some rather startling results.
Perhaps the most surprising result was that the GAD group exhibited a slightly
higher hit rate than the MDD group on DEP-P. As noted previously, the DEP-P subscale
measures constructs such as physical functioning, energy, and activity, as well as level of
sleep pattern disturbance (Morey, 1991). These concepts have considerable overlap with
the associated symptom criterion for GAD (APA, 2000). The results obtained here are
consistent with those of Brown, Marten, and Barlow (1995) who found that the
associated symptom criterion for GAD in the DSM-IV (APA, 1994) did not significantly
discriminate patients with GAD from those with MDD or Dysthymic Disorder. One
implication for the current findings is that the DEP-P subscale does not adequately
differentiate between the somatic symptoms of MDD and GAD. In contrast, the other two
DEP subscales, DEP-C and DEP-A, both had much higher hit rates for the MDD group
than the GAD group, which suggests that they are useful in differentiating between the
two disorders.
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Also unexpected were the results of the hit rates by each of the three diagnostic
groups on the SCZ-T subscale. Specifically, all of the groups had hit rates between 53.1%
and 56.3%, and mean elevations between 62.32T and 66.12T. As discussed previously,
SCZ-T is designed to measure thought processes that are marked by confusion and
difficulty concentrating (Morey, 1991). As with the aforementioned similarity of these
constructs to a cognitive symptom of MDD, they are also related to one of the six
criterion symptoms of GAD (APA, 2000). Given this, it is not surprising that the hit rates
and mean elevations for the MDD and GAD groups were virtually identical. In contrast,
the nearly matching hit rates and mean elevations for the MDD and OD groups seem
improbable given the vast heterogeneity of diagnoses in the OD group. One implication
of this finding is that regardless of diagnosis, university students who seek services at the
counseling center are experiencing similar and somewhat elevated levels of thought
disruption in the form of confusion and/or difficulty concentrating.
Although the MAN-G subscale was shown to be fairly capable of detecting the
presence of MDD, it does not appear useful for discriminating between MDD and GAD.
The hit rates and mean elevations for the MDD and GAD groups on the MAN-G subscale
were 70.4% and 64.6%, and 46.36T and 47.63T, respectively. The MAN-G subscale is
designed to measure self-esteem and grandiose thoughts such as possessing special and
unique talents that will lead to fortune and fame (Morey, 1991). Considering one of the
nine criterion symptoms of MDD is feelings of worthlessness (APA, 2000), and
anecdotal evidence that many university counseling center clients suffering from MDD
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express a sense of hopelessness, it is expected that the MAN-G subscale would be
suppressed for the MDD group. One explanation for the similar suppression seen in the
GAD group is that the tendency to worry about the future may impact the responses to
the items in the MAN-G subscale that allude to a successful future. Finally, as with
several of the other subscales already discussed, the mean elevation for MAN-G in the
MDD group is consistent with the findings Morey (1991) obtained from his MDD
sample. This lends further credence to the notion that university counseling center clients
are similar to Morey’s clinical population in their presentation of MDD.
Curiously, when the mean scale/subscale elevations are examined for the MDD
sample used by Morey (1991), the choice regarding scales/subscales to include in the
DCC for MDD is confusing. In particular, DEP-P and SCZ-T have mean elevations that
place them very near the boundary for relative elevation, which as previously noted
would likely yield a hit rate in the 50% range. This presumed result is consistent with
those obtained in the present study for DEP-P and SCZ-T. Furthermore, the mean
elevation for SCZ-S in the MDD sample used by Morey (1991) is below the boundary for
relative elevation and would probably result in a hit rate well below 50% for reasons
previously explained. Again, this assumed hit rate is consistent with the results obtained
in the present study for SCZ-S.
Beyond the three scales/subscales of the DCC for MDD that the present study
found to be valid for the purpose of detecting the presence of MDD (DEP-C, DEP-A, and
MAN-G), the SUI scale would be the only additional scale/subscale to be valid for this
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purpose in the MDD sample used by Morey (1991). As such, the DCC for MDD would
have only four of seven scales/subscales that were valid, which leads to the conclusion
that overall the DCC for MDD is not valid for use with the MDD sample used by Morey
(1991). One implication of this presumed conclusion is that the previously discussed
overall lack of validity demonstrated by the DCC for MDD with university counseling
center clients is unlikely a result of significant differences in presentation of MDD with
university counseling center clients. More importantly, the suggested conclusion calls
into question the validity of all the DCC’s. Future research should focus on examining
each of the DCC’s to make this determination.
Diagnostic Consideration Cluster for GAD
Similar to the DCC for MDD, it was hypothesized that the DCC for GAD would
be shown to be valid when used with university counseling center clients. Consistent with
the findings for the DCC for MDD, the results indicated that only 3.8% of the GAD
group demonstrated all of the scale/subscale elevations and suppressions (see Appendix
G for complete results of the DCC analyses). As this outcome was so deviant from my
expectations, I decided to examine each of the four scales/subscales individually. The
rationale for these additional analyses was the same as that described for the MDD DCC.
The results of the individual scales/subscales showed that ANX and ANX-A had
hit rates greater than 80%, and ARD and SCZ had hit rates below 27%. These findings
suggest that ANX and ANX-A are valid for the purpose of detecting the presence of
GAD in university counseling center clients, and ARD and SCZ are not valid for this
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purpose. Although the hit rates for two of the individual scales were lower than any of the
hit rates for the individual scales/subscales of the MDD DCC, the slightly higher hit rate
for the overall GAD DCC (3.8% versus 2.2%) is most likely explained by the lower
number of scales/subscales required to meet criteria (four versus seven). Taken together,
these results indicate the DCC for GAD is not valid for detecting the presence of GAD
with the population sampled in this study.
When the graphs containing the mean PAI full scale and subscale elevations for
the GAD group are examined in Appendix E, it is possible to visualize why the preceding
results were obtained. The graphs contain a solid yellow line that represents the mean
MCE for the GAD group, and two dashed yellow lines above and below the mean MCE
line that represent the boundaries for relative elevation and suppression. As shown in the
GAD scale and subscale graphs, the mean elevations for ANX and ANX-A are a
considerable distance above the cutoff for relative elevation. Accordingly, each
scale/subscale demonstrated a hit rate greater than 80%. SCZ and ARD are both above
the cutoff for relative suppression and show low hit rates as a result. In fact, SCZ is
nearly equal to the mean MCE for the GAD group, and ARD is actually above the mean
MCE. The respective hit rates of 26.6% and 15.2% are consistent with this observation.
The hit rate of 15.2% for ARD was in stark contrast to the hypothesized result. It
is important to keep in mind that the hit rate is based on the MCE, and thus an extremely
small MCE could account for such a low hit rate when determining relative suppression;
however, in the case of the GAD group, the mean MCE was 55.54T, which is above the
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community norm of 50T. In fact, as can be seen in Appendix F, the mean elevation on the
ARD scale for the GAD group was 59.20T, which is above the mean MCE. This result is
surprising because it shows that not only is the ARD scale not relatively suppressed as
suggested by the DCC for GAD, but also it is actually elevated relative to the mean MCE.
Furthermore, the ARD scale showed the third highest mean elevation of all the full scales
for the GAD group, lower only than the ANX and DEP scales.
The ARD scale measures constructs related to three different areas of anxiety
disorders: (1) fears associated with specific phobias, (2) thoughts and behaviors of an
obsessive-compulsive nature, and (3) troublesome occurrences related to a traumatic
event (Morey, 1991). Although the mean elevation for ARD was not clinically
significant, it was raised compared to the community norm of 50T. Morey (1991)
suggests that an ARD score in the range seen here is indicative of an individual who has
little self-confidence and may have some specific fears or worries. The lack of selfconfidence is consistent with the finding previously noted for the MAN-G subscale which
was relatively suppressed for the GAD group. Another possible explanation for the
results obtained in the present study is that the specific item content of the ARD scale
may contain fears or worries that are part of an individual’s pattern of generalized worry
associated with GAD, thus they endorse those particular items, which leads to an elevated
score on the ARD scale. Unfortunately, Morey (1991) does not provide mean
scale/subscale elevations for a sample of patients diagnosed with GAD as he did for a
sample that had received a diagnosis of MDD. As a result, the previously discussed
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comparisons between the MDD group in the present study and the MDD sample used by
Morey (1991) cannot be made with the GAD group.
The SCZ scale had a hit rate of 26.6% and mean elevation of 55.33T for the GAD
group. This result was surprising because not only is the ARD scale not relatively
suppressed as suggested by the DCC for GAD, but also it is actually nearly equal to the
mean MCE of 55.54T. Although the mean elevation for SCZ was not clinically
significant, it was raised compared to the community norm of 50T.
SCZ is designed to measure several aspects of Schizophrenia including unusual
beliefs and perceptions, social anhedonia and lack of social competence, and difficulties
related to concentration, attention, and associational processes (Morey, 1991). The
difficulty with concentration and attention is consistent with the finding previously noted
for the SCZ-T subscale which was elevated relative to the mean MCE for the GAD
group. Also, as explained earlier, these symptoms are related to the criterion symptoms of
GAD (APA, 2000), and thus an elevation on SCZ-T is not surprising. When the other
SCZ subscales are examined for the GAD group, we find that SCZ-P and SCZ-S have
mean elevations of 45.76T and 53.09T, respectively. Again, these results are consistent
with expectations for an individual diagnosed with GAD, who would be presumed to
have no psychotic symptoms and exhibit fairly normal social functioning. Given the
elevation on SCZ-T, nearly normal elevation on SCZ-S, and the suppression on SCZ-P, it
is understandable that the full scale score for SCZ, which is calculated from these three
subscales, would be in the normal range, showing little elevation or suppression.
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As previously mentioned, Morey and Hopwood (2007) suggest that in addition to
using the DCC’s to detect the presence of certain psychological disorders, they can be
useful for differential diagnosis. Based on this assumption, it was decided a priori to
examine the DCC for GAD using the MDD and OD groups, and compare these results
with those for the GAD group as a means of inspecting the validity of the authors’ claim.
Given the results of the analyses on the GAD group, these additional computations were
unnecessary because it was not possible for the DCC for GAD to be valid for differential
diagnosis. Nevertheless, the results of the analyses with the MDD and OD groups
revealed some interesting results.
Perhaps most surprising, the GAD group exhibited a much lower hit rate (15.2%)
than the MDD and OD groups (34.1% and 26.8%) on ARD. The mean scale elevations
for GAD, MDD, and OD were 59.20T, 56.87T, and 57.27T. Given that the DCC for GAD
expects ARD to be relatively suppressed, it is unexpected that not only is this not the
case, but also it has the highest mean elevation of all three diagnostic groups.
As noted above, the ARD scale is designed to measure constructs related to three
different areas of anxiety disorders: (1) fears associated with specific phobias, (2)
thoughts and behaviors of an obsessive-compulsive nature, and (3) troublesome
occurrences related to a traumatic event (Morey, 1991). Potential explanations for the
elevation seen with the GAD group were described above. One possible reason for the
lower mean elevations of the MDD and OD groups can be drawn from an examination of
the ARD subscale elevations. In particular, the GAD group exhibited a higher elevation
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than the MDD and OD groups on the ARD-P subscale (59.92T, 53.99T, and 54.14T).
ARD-P is designed to measure phobic behaviors that may be interfering with an
individual’s functioning (Morey, 1991). These results are unexpected, particularly for the
comparison between the GAD and OD groups. There were an undetermined number of
individuals in the OD group with a diagnosis of specific phobia. The amount of impact
these diagnoses would have had on the mean elevation of ARD-P for the OD group is
uncertain, however. One implication of the results found here is that the ARD-P subscale
may not be adequately differentiating between specific phobias and generalized worry as
related to their impact on individual functioning. Future research could address this
concern by examining the results of the ARD-P subscale for individuals diagnosed with
specific phobias and GAD.
The ANX scale and ANX-A subscale were determined to be valid for the purpose
of detecting the presence of GAD in university counseling center clients. Furthermore, it
appears that they are useful for differentiating between GAD, MDD, and OD. The hit
rates for the GAD, MDD, and OD groups on the ANX scale and ANX-A subscale were:
(1) GAD, 93.7% and 83.5%, (2) MDD, 52.6% and 44.4%, and (3) OD, 58.6% and 49.0%.
The mean elevations for the GAD, MDD, and OD groups on the ANX scale and ANX-A
subscale were: (1) GAD, 75.80T and 71.22T, (2) MDD, 63.47T and 60.72T, and (3) OD,
64.41T and 61.71T.
Overall, the DCC for GAD was determined to be invalid for detecting the
presence of GAD in university counseling center clients, as only two of the four
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scales/subscales demonstrated acceptable hit rates. The findings for the DCC for GAD
are consistent with the results obtained for the DCC for MDD. Based upon a comparison
between the mean elevations in the MDD sample used by Morey (1991) and the DCC for
MDD, it was hypothesized that the overall lack of validity demonstrated by the DCC for
MDD with university counseling center clients was unlikely a result of significant
differences in presentation of MDD with this population. Although a similar comparison
could not be made for the DCC for GAD due to the lack of reported mean elevations for a
GAD sample (Morey, 1991), it is not entirely unreasonable to assume that the overall
lack of validity demonstrated by the DCC for GAD with university counseling center
clients was also unlikely a result of significant differences in presentation of GAD with
this population.
Taken together, all of these results and hypotheses provide further support for the
aforementioned concern regarding the validity of all the DCC’s. As such, it appears there
is substantial need for future research to examine the validity of each of the DCC’s.
Meanwhile, I suggest that considerable caution be exercised when attempting to use the
DCC’s for the purpose of diagnosis.
Proposed Diagnostic Consideration Clusters for MDD and GAD
Due to the surprising results of the analyses on the DCC’s for MDD and GAD, I
decided to perform post-hoc analyses using the data from the present study to develop
DCC’s for MDD and GAD that would be more appropriate to use with university
counseling center clients. The DCC’s were designed to identify PAI scales/subscales that
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are typically elevated or suppressed when a particular disorder is present (Morey &
Hopwood, 2007). As such, it could be stated that the goal of the DCC’s is to detect the
presence of specific disorders. Based on this goal, the most precise DCC for a given
disorder would be composed of the scales/subscales that most frequently meet criteria for
elevation or suppression when the PAI is administered to individuals from that diagnostic
group. Determining which scales/subscales would be most appropriate is not a simple
task as several factors influence the likelihood that each individual in a diagnostic group
would demonstrate similar scale/subscale elevations and suppressions relative to their
MCE.
The design of a valid DCC is facilitated by prior knowledge of scale/subscale
elevations for a given diagnosis. One process that can be used to select scales/subscales
involves examining the mean scale/subscale elevations for a given diagnosis; however, it
is important to be aware of certain issues associated with this approach. First, when
looking at an individual PAI profile, it is clear that the scales/subscales that are above or
below the cutoffs for relative elevation and suppression meet criteria, but this is not
necessarily true when mean PAI profile data is being examined. For example, if the full
scale and subscale graphs for MDD and GAD in Appendix E are inspected, it is easy to
visualize the scales/subscales that are above or below the cutoffs for relative elevation
and suppression. However, these graphs use scale/subscale values that represent the
average scale/subscale scores of all the participants from each diagnosis. As such, it is not
appropriate to assume that a mean scale/subscale score that meets criteria for elevation or
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suppression would also meet criteria for the majority of individuals with that diagnosis.
The reason for this is that the amount of variability within a diagnostic group for that
particular scale/subscale would greatly impact the percentage of individuals who meet
criteria.
One way to account for within-group variability on a given scale/subscale is to
take the standard deviation into consideration. Based on the assumption that the data for
each scale/subscale will be normally distributed for a given diagnostic group, it is
possible to make use of the available knowledge related to this type of data. In particular,
we can calculate the percentage of participants that will exist above and below a
particular scale/subscale score based on the standard deviation. The selection of
scales/subscales for the proposed DCC’s for MDD and GAD with university counseling
center clients was made using the preceding information.
The process for scale/subscale selection described below was used for the MDD
and GAD diagnostic groups separately. The first step involved computing the absolute
value of the difference between each individual mean scale/subscale T score and the
mean MCE (e.g., for MDD group, mean DEP-C = 73.43T; mean MCE = 57.60T; so DEPC minus mean MCE = 15.83T). In essence, the result of this calculation for each
scale/subscale provided information regarding its distance from the mean MCE. These
computed values were referred to as elevation/suppression.
The second step involved multiplying the standard deviation of each
scale/subscale by the amount of standard deviation required to meet the desired hit rate.
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For instance, using a normal distribution, we know that from 0.5244 standard deviations
below the mean, 70% of the area under the normal curve exists above that point.
Therefore, to help determine the various mean T scores needed by each individual
scale/subscale to achieve a 70% hit rate, the standard deviation of each scale/subscale
was multiplied by 0.5244 (e.g., for MDD group, DEP-C SD = 14.17T; so DEP-C SD
times 0.5244 = 7.43T). Basically, the result of this calculation for each scale/subscale
provided information regarding how far past the boundary for elevation or suppression its
mean T score needed to be in order to achieve the desired hit rate. These results were
referred to as SD-scaled (e.g., for MDD group, DEP-C SD-scaled = 7.43T; mean MCE =
57.60T; boundary for elevation = mean MCE + 5.0 = 62.60T; thus the mean DEP-C T
score must be 7.43T above 62.60T to achieve a minimum hit rate of 70%).
The final step involved subtracting the value of SD-scaled for each scale/subscale
from the value of elevation/suppression for each scale/subscale (e.g., for MDD group,
DEP-C elevation/suppression = 15.83T; DEP-C SD-scaled = 7.43T; so 15.83T minus
7.43T = 8.40T). Essentially, the result of this calculation for each scale/subscale provided
the location of the point above which 70% of the participants T scores resided. This point
was in relation to the mean MCE so that a negative value indicated a point below the
mean MCE, and a positive value indicated a point above the mean MCE. Given that the
boundaries for elevation and suppression are defined to be 5.0T above and below the
MCE, any scale/subscale that had a final result of positive 5.0T or greater could be
included in the DCC with the expectation that it would achieve at least a 70% hit rate (the
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reason why a positive 5.0 value is used for both elevation and suppression is because the
choice was made early in the process to create the elevation/suppression values as
absolute values so they would all be positive).
The preceding calculations had been designed, organized, and conducted in such a
manner that it would be easy to change the value for the amount of standard deviation
required to meet a desired hit rate. This allowed multiple analyses to be performed using
various hit rates. It was decided to execute analyses with hit rates ranging from 60% to
95%, at intervals of 5%. Appendix K contains the proposed DCC’s for MDD and GAD
with university counseling center clients, including how they vary based on the hit rate
selected.
Examination of the results for the proposed DCC’s for MDD and GAD provide
some interesting insights. First, doing a comparison between the theoretical hit rates and
observed hit rates using the scales/subscales of the original DCC’s for MDD and GAD,
suggests that the method chosen to develop the proposed DCC’s is valid. In particular, for
the MDD group, DEP-A showed an observed hit rate of 83.7% and a calculated
theoretical hit rate greater than 80% and less than 85%. DEP-C had an observed hit rate
of 80.7% and a calculated theoretical hit rate greater than 75% and less than 80%. MANG demonstrated an observed hit rate of 70.4% and a calculated theoretical hit rate greater
than 70% and less than 75%. The four remaining scales/subscales of the DCC for MDD –
SCZ-T, DEP-P, SUI, and SCZ-S – had observed hit rates less than 60%, and none of
them were included in the analysis for the 60% or greater theoretical hit rate.
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The scales/subscales of the original DCC for GAD showed similar results. In
particular, ANX showed an observed hit rate of 93.7% and a calculated theoretical hit
rate greater than 90% and less than 95%. ANX-A had an observed hit rate of 83.5% and a
calculated theoretical hit rate greater than 80% and less than 85%. The two remaining
scales/subscales of the DCC for GAD, ARD and SCZ, had observed hit rates less than
60% and neither of them were included in the analysis for the 60% or greater theoretical
hit rate. Taken together, the above results provide evidence in support of the validity of
the proposed DCC’s for MDD and GAD with university counseling center clients.
The choice to use multiple hit rates in the development of the proposed DCC’s for
MDD and GAD was based on a few considerations. First, it is conceivable that depending
on the particular situation the DCC’s are being used for, the clinician may want to include
any scale/subscale with a 60% or greater hit rate, or he/she may choose to use only the
scales/subscales with much higher hit rates. Secondly, by including additional
scales/subscales in the DCC’s that meet criteria at a lower frequency, it provides the
clinician with the opportunity to make decisions based on the relative importance of a
given scale/subscale. For instance, for a particular patient, if the scales/subscales with the
highest probability of meeting the associated criteria fail, and yet most of the
scales/subscales with the lowest probability of meeting criteria succeed, it is plausible
that the patient is not presenting with the disorder related to the DCC under
consideration. Conversely, if a given patient meets criteria for the scales/subscales with
the highest probabilities and not for those with the lowest probabilities, it may be
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reasonable to conclude that the patient does have the disorder associated with the DCC
being used. However, if the relative probabilities of the various scales/subscales were not
known, it is likely that the choice would be based on number of hits versus misses. In this
case, the opposite diagnostic decisions would be made for the scenarios described above.
Perhaps the most surprising aspect of the results for the proposed DCC’s for
MDD and GAD is the number of scales/subscales that meet criteria with considerable
frequency. In particular, selecting 75% as the minimum required hit rate, the DCC for
MDD would contain only three scales/subscales: (1) DEP-A, (2) DEP, and (3) DEP-C.
Using the same hit rate, the DCC for GAD would contain only four scales: (1) ANX-C,
(2) ANX, (3) ANX-A, and (4) ANX-P.
Several concerns arise from the above findings. First, each DCC contains only the
scale/subscales related to its associated diagnosis. Given this, it could be argued that the
DCC’s are not useful for assisting in diagnosis because a clinician could simply examine
the elevation for each of the related scale/subscales without needing to make the
additional calculations required for the DCC’s. Secondly, a hit rate of 75% means that
only three out of four patients being administered the PAI would show a particular DCC
scale/subscale elevation. Although this may be acceptable to some clinicians, it is
presumable that many practitioners would choose not to rely on something that may not
detect 25% of the relevant scale/subscale elevations. Furthermore, as a result of the hit
rate being for each individual scale/subscale rather than the DCC as a whole, when only
three or four scales/subscales exist for a particular DCC, it is entirely possible none of the
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scales/subscales would meet criteria for a given PAI profile. This provides additional
support to the notion that DCC’s may not be a useful tool for diagnostic assessment.
Discriminant Analysis on MDD and OD
The hypothesis for the DA on MDD and OD was that the following scales and
subscale would be found to discriminate between the two diagnostic groups: (1) DEP, (2)
SUI, and (3) MAN-G. The results of the DA revealed that together, (1) DEP, (2) ANX,
(3) SUI, and (4) ANT-E were capable of accurately classifying a given PAI profile into
the appropriate diagnostic group. Two of the three hypothesized scales/subscales were
selected for inclusion in the discriminant function, and one additional scale, ANX, was
also chosen. At first glance these findings may appear to only partially support the
hypothesis, but further examination can provide understanding into how the selection of
ANT-E is consistent with the reasoning that was used in predicting the inclusion of
MAN-G. Furthermore, beyond the scales/subscales that were hypothesized, the addition
of the ANX scale can be elucidated when certain aspects of the data are taken into
consideration; first, however, clarification will be provided regarding the meaning and
appropriate interpretation of the DA results.
It is important to have a clear understanding of two aspects regarding this and the
other two DA’s: (1) what the results do and do not tell us about the data in general and
the PAI scales/subscales in particular, and (2) how the results can be utilized. As already
described (see Chapter 3, section on Analyses), DA can be used for multiple purposes
including the creation of discriminant functions that are capable of classifying individual
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cases into the appropriate group with a reasonably high level of accuracy. Additionally,
when the choice is made to use the stepwise method of DA, as was the case for the
present study, these discriminant functions will contain the fewest independent variables
(PAI scales/subscales) necessary for the task. Furthermore, the variables that are selected
for inclusion will be those that provide the greatest discriminatory power. From this, it
would be easy to assume that the scales/subscales that possess the largest differences in
elevation between groups would be the ones included in the discriminant function. Were
this the case, one could simply look at the graphs showing the mean scale/subscale
elevations of the two diagnoses under consideration (see Appendix E for the full scale
and subscale graphs that contain only MDD and OD together) and find the
scales/subscales that visibly showed the maximum discrepancies between the diagnoses;
however, it turns out this is not the case. The reason the process is not that simple is due
to both the nature of the data in this study as well as the characteristics of the stepwise
procedure (again, see Chapter 3, section on Analyses, for more details).
An examination of the results of the DA on MDD and OD that utilizes the
aforementioned graphs can help elucidate the process leading to the eventual discriminant
function. When the stepwise method selects the first scale/subscale, it looks for the one
exhibiting the greatest difference between the two diagnoses; however, for reasons
described in the previous section for the proposed DCC’s for MDD and GAD, this will
not necessarily be the scale/subscale with the greatest between groups mean elevation
difference due to the amount of within groups variability for a given scale/subscale.
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Looking at the full scale and subscale graphs in Appendix E as well as the numerical
values for the mean scale/subscale elevations (Appendix F) for MDD and OD, it is clear
that the three scales/subscales with the largest between groups differences are DEP, DEPC, and DEP-A. As it turns out, the first scale/subscale selected by the DA is the DEP full
scale.
Based on the prior description regarding the attributes of the stepwise procedure,
the next scale/subscale selected is unlikely to be either DEP-C or DEP-A because they
are highly correlated with the DEP scale. Returning to the graphs, the SUI scale appears
to have the next largest between groups disparity. Interestingly, it is not the next
scale/subscale selected by the DA; the ANX scale is. A look at the graph shows that
MDD and OD have nearly identical mean elevations on the ANX scale, which begs the
question why it was chosen, particularly over the SUI scale. Again, the correlation issue
is likely the reason for this. In particular, SUI is conceptually expected to be highly
correlated with MDD, and with that in mind, it seems plausible that it is not the next most
discriminatory scale/subscale given that the DEP scale has already been included. Once
the ANX scale is added second, the SUI scale is determined to contain the next greatest
discriminatory power on the variance that remains between the diagnoses once the
variance accounted for by the first two scales, DEP and ANX, has been removed.
The fourth and final scale/subscale chosen for the discriminant function was the
ANT-E subscale. A quick look at the graphs would suggest that there are at least a few
remaining scales/subscales that appear to have larger between groups differences,
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especially MAN-G and BOR-I; however, they are passed over in favor of ANT-E. The
explanation for this is likely due to correlation issues again. Although it is not possible to
state with certainty what actually led to this result, what is certain is that ANT-E provided
the greatest reduction in the remaining variance between the two diagnoses. Following
the inclusion of ANT-E, the DA determined there were no additional scales/subscales
that could significantly improve the discriminatory power of the function.
Working through the stepwise selection process for the DA on MDD and OD
helps clarify what the scales/subscales chosen for inclusion in the discriminant function
do and do not explain about the data under consideration. First, the scales/subscales that
are selected by the DA do not provide insight into which scales/subscales have the
greatest T score differences between the two diagnostic groups. Second, the inclusion of a
scale/subscale in a discriminant function does not indicate anything with regards to the
degree of elevation exhibited by that scale/subscale in either diagnostic group.
Specifically, inclusion does not signify that the scale/subscale elevation will typically be
very low, very high, or moderate. As such, when examining an individual PAI profile for
the purpose of interpretation, using only the knowledge that these four scales/subscales
comprise the discriminant function does not indicate the characteristics of the profile in
general or each individual scale/subscale in particular. In fact, about the only statement
that can be made with significant confidence is that when these specific scales/subscales
are assigned the appropriate coefficients, collectively they can be used to classify an
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individual PAI profile into the appropriate diagnostic category with a level of accuracy
that is significant.
As already noted, the DCC’s were designed in such a way that the PAI
scales/subscales they contain signify those which are most important and potentially
helpful to evaluate when interpreting an individual profile for specific diagnostic
possibilities. Specifically, the scales/subscales of a particular DCC should be those that
exhibit the highest and lowest elevations in the PAI profile for the corresponding
diagnosis. Based on the discussion above, it becomes clear that the scales/subscales
selected by DA are not able to provide the same type of information. Furthermore, the
scales/subscales chosen for the DCC’s are based solely on profile data that represents one
specific diagnosis, while those selected by DA are based on a comparison of the profile
data for two separate diagnostic categories. Taken together, all of the aforementioned
differences between the construction of a DCC and a discriminant function create a
situation where it is not valid to make direct, one-to-one comparisons between the
scales/subscales of the DCC’s and those selected by DA. Although there is modest
overlap of the scales/subscales obtained in the computations for the DCC’s and the DA’s
in this study, the basis on which a given scale/subscale is selected by each analysis is
generally quite different, even though it may appear on the surface to be for the same or
similar reasons.
As noted above, two of the scales/subscales selected by the DA were contrary to
the hypothesis for the DA on MDD and OD. First, the ANT-E subscale was included in
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the discriminant function while the MAN-G subscale was not. The MAN-G was
predicted for inclusion because the mean profile for the MDD sample Morey (1991) used
reveals that the typical elevation for MAN-G is well below 50T. For several reasons
described in the section regarding the DCC for MDD, MAN-G is expected to be
suppressed for an individual suffering from MDD. It turns out that ANT-E, which is
intended to be a measure of egocentricity (Morey, 1991), measures very similar
constructs. In fact, Morey (1991) suggests that high scores on ANT-E are indicative of a
person who experiences little guilt or remorse; therefore, low scores on ANT-E may
indicate excessive guilt, which is one of the nine criterion symptoms for MDD (APA,
2000). Therefore, for reasons very similar to those of MAN-G, it is expected that ANT-E
would be suppressed in individuals presenting with MDD.
The ANX scale was included in the discriminant function although it was not
hypothesized to be one of the selected scales/subscales. An examination of the
characteristics of the OD group can provide a possible explanation for the selection of
ANX by the DA. As previously defined, the OD group is composed of every client who
was not diagnosed with: (1) MDD with no co-morbid Axis I disorder, or (2) GAD with
no co-morbid Axis I disorder. Notably, due to the selected criteria for the MDD and GAD
groups, it is possible for the OD group to include, among others, a diagnosis that consists
of: (1) MDD and GAD, (2) MDD and one or more (non-GAD) co-morbid Axis I
disorder(s), and (3) GAD and one or more (non-MDD) co-morbid Axis I disorder(s). In
fact, the OD group does contain several of the three described diagnoses; however, the
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exact number is not known at the time of this writing because that data was not recorded
during the process of categorizing the PAI profiles into the diagnostic groups chosen for
this study.
Although exact figures are not available at the time of this writing, it is possible to
generate an estimate of the number of participants in the OD group with an MDD or
GAD diagnosis. As mentioned earlier, a report that contained diagnostic information was
produced using Titanium software. The report provides information for each of the
diagnoses described in the DSM-IV-TR (APA, 2000), including the percentage of clients
who received that diagnosis. Unfortunately, given the significant number of possible
variations for the MDD diagnosis (single episode, recurrent, mild, moderate, full
remission, etc.), it is not a simple matter to estimate how many participants in the OD
group had a diagnosis of MDD. After removing the MDD diagnoses that were given a
specifier of either partial or full remission (the MDD group was created using the same
guideline), the remaining MDD diagnoses were received by 29.8% of clients. This figure
is likely misleading (to an unknown degree) due to the possibility that at one point a
given client could have received a diagnosis of MDD, single episode, mild, and then later
received a diagnosis of MDD, recurrent, mild. The potential also exists that a particular
client could have received two separate diagnoses of MDD that varied only in level of
severity (mild, moderate, or severe with/without psychotic features). Each of these
occurrences would inflate the total percentage of clients who had a diagnosis of MDD,
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but it is not possible from the data available at the time of this writing to determine the
extent this value might be exaggerated.
Given the unknown error in the approximation of clients diagnosed with MDD, it
was decided to proceed with the current value while bearing in mind that it is likely
somewhat inflated. Based on the value of 29.8%, approximately 459 clients in the sample
used for this study received a diagnosis of MDD. We know that 135 clients received a
diagnosis of MDD with no co-morbid Axis I disorder, which leaves around 324 clients in
the OD group with a diagnosis of MDD and one or more additional Axis I disorder(s).
The percentage of clients who received a diagnosis of GAD was 18.0% (GAD does not
have multiple diagnoses as does MDD), which extrapolates out to an estimate of 277
clients. The GAD group consisted of 79 participants, which leaves approximately 198
participants in the OD group with a diagnosis of GAD and one or more additional Axis I
disorder(s).
Returning to the unpredicted inclusion of the ANX scale in the discriminant
function for MDD and OD, the preceding discussion regarding the composition of the
OD group provides one possible explanation for this finding. Specifically, the OD group
contained roughly 198 participants who had GAD as a part of their diagnostic profile.
This may account for the ability of ANX to discriminate between the MDD and OD
groups. This hypothesis becomes even more plausible when the mean scale elevations for
ANX are examined. In particular, the MDD (M = 63.47T; SD = 11.68) and OD (M =
64.41T; SD = 13.91) groups demonstrated mean ANX scale elevations that were within
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1T of each other. Based on the idea that significant differences in scale elevations
between two diagnostic groups should best provide discriminant power, it seems
unimaginable that the ANX scale could discriminate between the MDD and OD group
when the corresponding mean elevations are so similar. However, an examination of the
standard deviations reveals a proportionally larger variability in the OD group. It is
conceivable that this variation occurred due to the 198 or so GAD diagnoses in the OD
group having elevated scores on the ANX scale. If this is indeed the case, then it is very
believable that ANX could discriminate between MDD and OD despite the similar mean
scale elevations.
Although the above suppositions regarding the individual scales/subscales that
comprise the discriminant function for MDD and OD cannot be verified, there are some
aspects of the DA results that are definitive. In particular, the standardized canonical
coefficients assigned to each scale/subscale of the discriminant function (see Appendix
H) provide useful information in that they can be used to assess the importance of the
unique contribution to the discriminant function of each scale/subscale. Put another way,
they indicate the relative importance of the scales/subscales in predicting diagnostic
group. The standardized canonical coefficient with the maximum absolute value for the
discriminant function for MDD and OD belongs to the DEP scale (0.992); the ANX scale
is the second highest (-0.810). The interpretation of these findings is that the DEP scale
has the most predictive power of the four scales/subscales selected for the discriminant
function, and the ANX scale has about 81.7% (0.810/0.992) as much predictive power as
55

the DEP scale. The ANT-E subscale, which has the lowest standardized canonical
coefficient (-0.330), is roughly only one-third as powerful as the DEP scale for predicting
diagnostic category. Importantly, these coefficients change whenever a scale/subscale is
added or removed from the discriminant function; therefore, what cannot be inferred
from these results is how much predictive power the DEP, ANX, SUI, or ANT-E
scales/subscales have compared to each of the remaining PAI scales/subscales.
Once a discriminant function has been created, it can be used to classify
individual PAI profiles into one of two groups. This step involves multiplying the T score
of each scale/subscale in the discriminant function by its corresponding unstandardized
canonical discriminant coefficient, and summing those values to provide a single
numerical result. When the computed result is above a certain cutoff point, that
participant is classified into one diagnostic group, and when below the cutoff, it places
the participant into the other diagnostic group. To aid in this process, it is recommended
that prior probabilities (priors) be set proportional to group size when the two groups do
not have equal sample sizes, which is the case in the present instance (MDD: n = 135;
OD: n = 1327). Priors essentially act as weights in such a way as to direct more
participants towards the group with the larger prior value, and fewer participants towards
the group with the smaller prior value. For example, if the classification of MDD and OD
participants used proportionate priors (group size), they would be roughly .092 and .908,
respectively.
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Initially, when the classification was calculated for each of the MDD and OD
participants, the above proportional priors were used; however, this led to a significant
problem. With priors set to group size, 90.7% of the original grouped cases were
correctly classified, and classification was successful in 99.0% of the OD group, but only
8.9% of the MDD group. In terms of number of participants, this meant that only 12 of
the 135 participants in the MDD group were classified in the MDD category.
When priors were set equal (.5 and .5), classification was successful in 68.1% of
the MDD group, and 74.0% of the OD group. Of the original grouped cases, 73.5% were
correctly classified. Although the total hit rate is significantly lower in this second
classification (73.5% versus 90.7%), and the OD group’s classification rate decreased
from 99.0% to 74.0%, the MDD group increased from being correctly classified 8.9% of
the time to 68.1%. Given that the goal of this DA was to create a discriminant function
that was capable of taking the PAI profile of any client seeking treatment and detect,
identify and diagnose the presence of MDD. To this end, it was decided that the loss in
accuracy of correctly classifying the OD group was much less important than the gains
for the MDD group with priors set equal.
Furthermore, the composition of the OD group raises some interesting questions
regarding the second and final classification using the MDD and OD derived discriminant
function. In particular, the 26.0% of OD participants who were “incorrectly” classified
into the MDD group represent 345 participants. Earlier, a rough estimate for the number
of participants in the OD group with a diagnosis of MDD and one or more additional
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Axis I disorder(s) was calculated and determined to be around 324. Perhaps the similarity
between this estimated value and the actual number of participants from the OD group
who were classified as being in the MDD group is purely coincidence, but it is very
intriguing to consider the possibility that the majority of the 345 are comprised of the
rough estimate of 324 participants with an MDD diagnosis as part of the clinical picture.
Unfortunately, given the available data at the time of this writing there is no way to
determine if this is in fact the case, or even what percentage of the 345 has an MDD
diagnosis. If this proposed theory is even partially correct, it could be argued that the
“lower” hit rate for the OD group when using equal priors is actually a more accurate
representation of the PAI profiles being investigated than the 99.0% hit rate when priors
were set to group size.
The previous discussion highlights one of the limitations of the present DA. At a
basic level, one interpretation of the results from running a DA on MDD and OD is that
you can use the resultant discriminant function to examine an individual PAI profile and
predict if the client has MDD with no co-morbid Axis I disorder(s) or some other some
other diagnosis. If, however, the goal were to create a discriminant function that could
detect the existence of MDD regardless of the presence of another Axis I disorder, the
discriminant function developed here cannot be assumed to perform such an action. It is
suggested that a follow-up study be conducted that places any PAI profile with an
associated MDD diagnosis into the MDD group to determine how, if at all, the resulting
discriminant function would differ from that created here.
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Discriminant Analysis on GAD and OD
It was hypothesized that (1) the ANX-A subscale and (2) the SCZ full scale would
be found to discriminate between the GAD and OD diagnostic groups. The results of the
DA revealed that together, (1) ANX-C, (2) BOR-I, and (3) DEP-A were capable of
accurately categorizing a given PAI profile into the appropriate diagnostic group. Neither
of the two hypothesized scales/subscales was selected for inclusion in the discriminant
function, and one additional scale, DEP-A, was included. On the surface, these results do
not support the predicted outcome; however, for several reasons described in the previous
section, it is not a trivial matter to theorize what scales/subscales would be selected by
DA. Furthermore, in the case of the GAD group, a mean profile was not available for use
in assisting with scale/subscale predictions as was the case for the MDD group. If the
process described in the previous section for the selection of scales by the DA for the
MDD and OD groups is followed here, insight into the 3 subscales that were selected in
this DA can be gained. It is left as an exercise for the reader to step through the
procedure. As a reminder, Appendix E contains the full scale and subscale graphs that
display the GAD and OD groups together.
The inclusion of ANX-C as opposed to the predicted ANX-A is consistent with
the result obtained from the computations used to create the proposed DCC for GAD,
which showed the ANX-C subscale to possess the highest hit rate of any scale/subscale
for the ANX diagnostic group (see Appendix K). In fact, the mean scale elevation for
ANX-C in the GAD group is the highest score of any scale/subscale of the three
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diagnostic groups created for this study (see Appendix F). As such, it is clear why it was
selected as the first scale/subscale by this DA.
As with the DA for MDD and OD, there was an unexpected scale chosen by the
DA for GAD and OD: in this instance, the DEP-A subscale. For the DA on MDD and
OD, the ANX scale was selected, and due to the OD group containing large numbers of
GAD diagnoses, it is intuitive that the ANX scale would help discriminate between the
two diagnostic groups. Following the same reasoning, it is understandable that the OD
group’s large number of MDD diagnoses, which was estimated to be around 324, would
account for the ability of DEP-A to discriminate between the GAD and OD diagnostic
groups in the present DA.
Reviewing the standardized canonical coefficients for the DA on GAD and OD
(see Appendix I) reveals that, as would be expected, the ANX-C subscale (1.197) has the
most predictive power of the three subscales used in the discriminant function. The BORI (-0.596) and DEP-A (-0.466) subscales are each a little less than half as powerful for the
purpose of predicting.
Similar to the classification for the MDD and OD groups, the selection of priors
that were proportional to group size was problematic for GAD and OD. In fact, the ratio
for the classification is even worse than it was for MDD and OD (GAD: n = 79; OD: n =
1327). For the same reasons explained in the classification of MDD and OD, it was
decided to set the priors equal (.5 and .5) for classifying GAD and OD. Using these
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values, classification was successful in 82.3% of the GAD group, and 77.2% of the OD
group. Of the original grouped cases, 77.5% were correctly classified.
A dynamic consistent with the one observed in the MDD and OD classification
presented itself here as well. Specifically, the 22.8% of OD participants who were
“incorrectly” classified into the GAD group represent 303 participants. As estimated
before, roughly 198 participants in the OD group have a diagnosis of GAD and one or
more additional Axis I disorder(s). As such, the OD group had about 50% more
participants placed in the GAD group than the approximate number who had a diagnosis
of GAD as part of the clinical picture (303 versus 198), which is not as accurate as the
results obtained from the MDD and OD classification (345 versus 324). However, the
result discovered here still generates the intriguing possibility that a significant number of
the 303 who were “incorrectly” classified are comprised of the estimated 198 participants
with a GAD diagnosis as part of the clinical picture. As with the previous classification, it
is not possible to determine the degree to which this relationship may exist due to the lack
of necessary data at the time of this writing.
Once again, consistent with the DA on MDD and OD, the above discussion
highlights one of the limitations of the present DA. At a basic level, one interpretation of
the results from running a DA on GAD and OD is that you can use the resultant
discriminant function to examine an individual PAI profile and predict if the client has
GAD with no co-morbid Axis I disorder(s) or some other some other diagnosis. If,
however, the goal were to create a discriminant function that could detect the existence of
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GAD regardless of the presence of another Axis I disorder, the discriminant function
developed here cannot be assumed to perform such an action. It is suggested that a
follow-up study be conducted that places any PAI profile with an associated GAD
diagnosis into the GAD group to determine how, if at all, the resulting discriminant
function would differ from the one just created.
Discriminant Analysis on MDD and GAD
The hypothesis for the DA on MDD and GAD was that the following scale and
subscales would be found to discriminate between the two diagnostic groups: (1) DEP-A,
(2) ANX-A, (3) SUI, (4) MAN-G, (5) SCZ-S, and (6) SCZ-T. The results of the DA
revealed that together, (1) ANX, (2) DEP-A, (3) BOR-S, (4) SCZ-P, (5) SOM-S, and (6)
MAN-G could accurately classify a given PAI profile into the appropriate diagnostic
group. Thus, only two of the six hypothesized scales/subscales were selected for
inclusion in the discriminant function, but one, ANX, was very similar to the suspected
ANX-A except that rather than the anxiety subscale being selected, the full scale was
chosen. As with the DA on GAD and OD, these results do not support the predicted
outcome; however, for several reasons already discussed, accurately predicting
scale/subscale selection for DA is often not possible. Additionally, the hypothesized
scales/subscales for this DA suffered from the same issue as the DA for GAD and OD;
namely that there was no mean GAD profile to utilize in developing the predicted
scales/subscales. Once again, following the aforementioned process in the DA on MDD
and OD, potential explanations for the selection of these six scales/subscales can be
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elucidated. It is left as an exercise for the reader to step through the procedure. As a
reminder, Appendix E contains the full scale and subscale graphs that display the MDD
and GAD groups together.
Some differences between this DA and the first two that were performed are
important to mention. First, the relationship between the two groups under consideration
for this DA is significantly different than the others. In particular, each of these groups
was composed of participants who met very narrowly defined criteria related to
diagnosis. In the first two DA’s, one of the two groups was extremely heterogeneous and
also included participants who had portions of their clinical presentation that overlapped
with the comparison group. In the present DA, this was not the case as each group
contained only the designated diagnosis, which theoretically should have led to much
more consistent PAI profiles with the additional benefit of minimal overlap with the
comparison group. Additionally, an enormous improvement in the ratio of group size
exists between these two groups.
An examination of the standardized canonical coefficients for the DA on MDD
and GAD (see Appendix J) reveals that the ANX (-1.139) and DEP-A (0.707)
scale/subscale have significantly more predictive power than the other four subscales in
the DA. This finding provides incremental validity for the depression and anxiety
scales/subscales of the PAI, particularly with a university counseling center population.
Given the unambiguous nature of each group, it is to be expected that the corresponding
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scales/subscales of the PAI, depression and anxiety, would provide a significant
proportion of the discriminatory power.
Classification for the DA on MDD and GAD was executed differently due to the
improvement in ratio of group size (GAD: n = 79; MDD: n = 135). As such, it was
determined that this classification could be performed as is typically recommended,
which entails using group sizes for the choice of priors. Using these values, classification
was successful in 93.3% of the MDD group, and 89.9% of the GAD group. Of the
original grouped cases, 92.1% were correctly classified. In terms of the number of PAI
profiles misclassified, 9 of the 135 profiles from the MDD group were misclassified as
GAD, and 8 of the 79 profiles from the GAD group were misclassified as MDD. The
exceptionally high hit rates obtained in this DA are likely influenced by a few factors.
First, the ability to select group sizes for the priors boosts accuracy above that seen for
the first two DA’s. Also, the well-defined nature of each group presumably facilitated the
ability to discriminate between them.
The applicability of the discriminant function computed for MDD and GAD is
significantly different from the previous two discriminant functions, and this
distinctiveness sheds light on an important limitation. Essentially, the discriminant
functions computed for MDD and OD, and GAD and OD, are capable of the following:
given a PAI profile of any university counseling center client, the diagnosis will be
determined to be either MDD (or GAD) with no co-morbid Axis I disorder, or something
else. To this end, it could be said that these two discriminant functions are useful for
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detecting the presence of the associated disorder (MDD or GAD), or to help rule-out the
disorder. In stark contrast, the discriminant function for MDD and GAD provides the
ability to do the following. Given a PAI profile of a university counseling center client
who has either MDD with no co-morbid Axis I disorder, or GAD with no co-morbid Axis
I disorder, the diagnosis will be determined, and thus differentiated, with a high degree of
confidence. To this end, it could be said that this function is useful for the task of
differentiating between MDD and GAD when the diagnosis has been narrowed to be one
of the two. As such, this discriminant function has a very specific application, while the
other two could presumably be used with every client. The benefit of such a precise
purpose is the extremely high level of accuracy achieved. Alternatively, the broader
application provided by the first two discriminant functions comes at the cost of a
significant decrease in accuracy.
Similar to the limitations noted for the first two discriminant functions, this one
was developed using data from participants who did not have a co-morbid Axis I
disorder. If the goal was to have a discriminant function that could be used for the task of
differentiating between MDD and GAD regardless of the presence of other Axis I
disorders, the discriminant function developed here cannot be assumed to perform such
an action. It is suggested that a follow-up study be conducted that places any PAI profile
with an associated MDD or GAD diagnosis into the corresponding diagnostic group to
determine how, if at all, the resulting discriminant function would differ from the one just
created.
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Limitations
There are a number of limitations in the present study, and those applicable to
only one or a few of the parts have been discussed in the corresponding sections above.
One limitation that applies to the study as a whole is the use of clinician’s diagnoses as a
criterion measure. It is widely accepted that considerable variability exists between
individual clinician’s diagnostic impressions. Given that the accuracy of the diagnoses
used in this study were not verified by a second clinician (except in those cases where the
treating clinician was a graduate student being supervised by a licensed psychologist), it
is conceivable that variation among clinicians adversely affected the diagnoses used for
classification in this study. To the extent that this occurred, the myriad analyses
conducted would have been based on PAI data that were erroneously believed to be
associated with correct diagnoses. Although the consistent results achieved in many
aspects of this study would suggest otherwise, it is still possible that variation in clinician
diagnoses adversely affected the results obtained.
Furthermore, it is possible that the clinician’s diagnostic decisions were
influenced by reviewing the results of the PAI prior to making a diagnosis. Although the
PAI results do provide interpretive hypotheses regarding diagnosis, they are merely
suggestions, and the clinician is still expected to consider all possible diagnoses that are
applicable to a client. Given the nature of this study and the data utilized, this was not a
66

variable that could be controlled, nor is it possible to estimate the impact it may have had
on diagnostic decisions. Again, as mentioned above, the consistency of the results
obtained across various analyses and diagnostic groups in the present study suggests that
the diagnoses used were accurate and reliable.
The choice to use DA for the purpose of developing discriminant functions that
could be utilized for diagnostic classification of individual PAI profiles may have led to
problematic results. Other statistical methods exist that can be used for classification
purposes, and perhaps different results would have been obtained had another method of
analysis been chosen, such as logistic regression. One weakness of multivariate
approaches such as DA is that weights (canonical discriminant function coefficients in
the present study) may not generalize well across various samples. The reasons for this
are that the weights can be affected by sample size, as well as the number and weighting
of predictors (Bernstein, 1988). Two directions for future research include: (1) using a
different statistical method on the data in this study to create the corresponding
discriminant functions, and then comparing those results to the ones obtained here, and
(2) conducting DA on data from new samples to determine how well the weights
obtained in this study generalize to another sample.
The data used for this study came from a single counseling center at a large
southeastern university; as such, the generalizability of this study is limited. It is possible
that the student population sampled here differs from other universities of varying size
and location. Furthermore, the potential exists that the students who seek services at the
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counseling center of this university present with significantly different concerns than
those at other universities. Although the CSCMH study (Locke, 2009) demonstrated that
the same types of clients and problems tend to be seen by all counseling centers
regardless of their parent institution, it is still possible that there are important variations
in the students seeking services at this counseling center. Replication of this study at
multiple university counseling centers across the U.S. may bolster the generalizability of
the results obtained here.
Future Directions
A number of future directions for research have been proposed throughout this
study. Combining several of the results and nuances that were revealed in this study, the
question arises as to how else the PAI might be utilized for the purpose of diagnosis. In
particular, are there methods that could provide more accurate diagnoses than those
developed to date? Similarly, could methods be discovered that provide equivalent
diagnostic accuracy of existing methods, yet with less analysis, effort, or time involved to
achieve the results?
One such possibility comes to mind based on some of the patterns observed in the
present study, as well as research conducted by Marlowe and Wetzler (1994). The
authors used DA to develop a number of discriminant functions using other popular
personality assessment instruments. They found that most of the functions created were
able to significantly discriminate patients who were depressed, manic, or psychotic from
controls. Despite the significance the authors observed for most of the functions, they
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found little improvement in diagnostic efficiency when compared to the use of singlescale elevations at specified cut scores. The findings obtained by Marlowe and Wetzler
(1994), and several patterns observed during the analyses of the present study, suggest
the need to conduct research on the PAI that compares the use of complicated equations
like those developed with DA, and simpler methods of analysis such as individual scale
elevations that make use of cut scores to determine inclusion in a diagnostic category.
Conclusions
Overall, the results of this study indicated that the Personality Assessment
Inventory can be used to diagnose and discriminate between Major Depressive Disorder
and Generalized Anxiety Disorder in a University Counseling Center. However, the
ability of the PAI to be utilized for this purpose varied as a function of the application of
the PAI results. In particular, it was found that the Diagnostic Consideration Clusters for
MDD and GAD were not capable of diagnosing the intended disorders, and were thus
incapable of discriminating between MDD and GAD. Furthermore, based on additional
analyses and the development of DCC’s for MDD and GAD using the data from the
present study, I questioned the viability of using DCC’s for the purpose of diagnosis and
suggested future research examine the validity of DCC’s for other psychiatric disorders to
aid in addressing the question of viability.
In contrast to the DCC’s, discriminant functions were created that were found to
accurately diagnose and discriminate between, (1) MDD and all other disorders, (2) GAD
and all other disorders, and (3) MDD and GAD. Although these discriminant functions
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were effective for the task of diagnosis and discrimination, they require significant effort
to develop initially and then additional effort and time to apply to PAI data. Given this
drawback to using discriminant functions, I questioned if it would be possible to obtain
similar results with less time and effort. Research conducted by Marlowe and Wetzler
(1994) suggests that it may be possible to achieve similar levels of diagnostic efficiency
by examining single-scale elevations at specified cut scores; therefore, future research
could expand upon the work done by these authors to include additional psychiatric
diagnoses and assessment instruments, particularly the PAI.
Given the prevalence of MDD and GAD as the two psychological disorders most
generally treated at university counseling centers, the clinically significant distress or
impairment they cause in important areas of functioning, and the difficulties clinicians
face in accurately diagnosing and discriminating between MDD and GAD, the results of
this study demonstrate a need to increase the use of the PAI as a part of the treatment
process, especially for the population sampled in this study.
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Appendix A
Major Depressive Disorder (MDD)
A. Presence of one or more Major Depressive Episodes, defined as:
A. Five (or more) of the following symptoms have been present during the same
two-week period and represent a change from previous functioning; at least one of
the symptoms is either (1) depressed mood or (2) loss of interest or pleasure.
Note: Do not include symptoms that are clearly due to a general medical
condition, or mood-incongruent delusions or hallucinations.
(1) depressed mood most of the day, nearly every day, as indicated by either
subjective report (e.g., feels sad or empty) or observation made by others (e.g.,
appears tearful). Note: In children and adolescents, can be irritable mood.
(2) markedly diminished interest or pleasure in all, or almost all, activities most of
the day, nearly every day (as indicated by either subjective account or
observation made by others).
(3) significant weight loss when not dieting or weight gain (e.g., a change of more
than 5% of body weight in a month), or decrease or increase in appetite nearly
every day. Note: In children, consider failure to make expected weight gains.
(4) insomnia or hypersomnia nearly every day
(5) psychomotor agitation or retardation nearly every day (observable by others,
not merely subjective feelings of restlessness or being slowed down)
(6) fatigue or loss of energy nearly every day
(7) feelings of worthlessness or excessive or inappropriate guilt (which may be
delusional) nearly every day (not merely self-reproach or guilt about being
sick)
(8) diminished ability to think or concentrate, or indecisiveness, nearly every day
(either by subjective account or as observed by others)
(9) recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation
without a specific plan, or a suicide attempt or a specific plan for committing
suicide
B. The symptoms do not meet criteria for a Mixed Episode.
C. The symptoms cause clinically significant distress or impairment in social,
occupational, or other important areas of functioning.
D. The symptoms are not due to the direct physiological effects of a substance (e.g.,
a drug of abuse, a medication) or a general medical condition (e.g.,
hyperthyroidism)
E. The symptoms are not better accounted for by Bereavement, i.e., after the loss of
a loved one, the symptoms persist for longer than 2 months or are characterized
by marked functional impairment, morbid preoccupation with worthlessness,
suicidal ideation, psychotic symptoms, or psychomotor retardation.
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Major Depressive Disorder (MDD) (continued)
B. The Major Depressive Episode is not better accounted for by Schizoaffective
Disorder and is not superimposed on Schizophrenia, Schizophreniform Disorder,
Delusional Disorder, or Psychotic Disorder Not Otherwise Specified.
C. There has never been a Manic Episode, a Mixed Episode, or a Hypomanic Episode.
Note: This exclusion does not apply if all of the manic-like, mixed-like, or
hypomanic-like episodes are substance or treatment induced or are due to the direct
physiological effects of a general medical condition.
Source: Adapted from “Diagnostic and Statistical Manual of Mental Disorders (4th ed.,
text revision, pp. 356, 369-371),” by American Psychiatric Association, 2000,
Washington, DC: Author.
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Appendix B
Generalized Anxiety Disorder (GAD)
A. Excessive anxiety and worry (apprehensive expectation), occurring more days than
not for at least six months, about a number of events or activities (such as work or
school performance).
B. The person finds it difficult to control the worry.
C. The anxiety and worry are associated with three (or more) of the following six
symptoms (with at least some symptoms present for more days than not for the past
six months). Note: Only one item is required in children.
(1) restlessness or feeling keyed up or on edge
(2) being easily fatigued
(3) difficulty concentrating or mind going blank
(4) irritability
(5) muscle tension
(6) sleep disturbance (difficulty falling or staying asleep, or restless unsatisfying
sleep)
D. The focus of the anxiety and worry is not confined to features of an Axis I disorder,
e.g., the anxiety or worry is not about having a Panic Attack (as in Panic Disorder),
being embarrassed in public (as in Social Phobia), being contaminated (as in
Obsessive-Compulsive Disorder), being away from home or close relatives (as in
Separation Anxiety Disorder), gaining weight (as in Anorexia Nervosa), having
multiple physical complaints (as in Somatization Disorder), or having a serious illness
(as in Hypochondriasis), and the anxiety and worry do not occur exclusively during
Posttraumatic Stress Disorder.
E. The anxiety, worry, or physical symptoms cause clinically significant distress or
impairment in social, occupational, or other important areas of functioning.
F. The disturbance is not due to the direct physiological effects of a substance (e.g., a
drug of abuse, a medication) or a general medical condition (e.g., hyperthyroidism)
and does not occur exclusively during a Mood Disorder, a Psychotic Disorder, or a
Pervasive Developmental Disorder.
Source: Adapted from “Diagnostic and Statistical Manual of Mental Disorders (4th ed.,
text revision, p. 476),” by American Psychiatric Association, 2000, Washington, DC:
Author.
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Appendix C
PAI Clinical, Treatment, and Interpersonal Scales
Scale

Description

Clinical Scales
Somatic Complaints (SOM)

Focuses on preoccupation with health matters and somatic complaints
related to somatization or conversion disorders. Subscales include
Conversion (SOM-C), Somatization (SOM-S), and Health Concerns
(SOM- H).
Anxiety (ANX)
Focuses on phenomenology and observable signs of anxiety with an
emphasis on assessment across different response modalities. Subscales
include Cognitive (ANX-C), Affective (ANX-A), and Physiological
(ANX-P).
Anxiety-Related Disorders (ARD) Focuses on symptoms and behaviors related to specific anxiety
disorders. Subscales include Obsessive-Compulsive (ARD-O), Phobias
(ARD-P), and Traumatic Stress (ARD-T).
Depression (DEP)
Focuses on symptoms and phenomenology of depressive disorders.
Subscales include Cognitive (DEP-C), Affective (DEP-A), and
Physiological (DEP-P).
Mania (MAN)
Focuses on affective, cognitive, and behavioral symptoms of mania and
hypomania. Subscales include Activity Level (MAN-A), Grandiosity
(MAN-G), and Irritability (MAN-I).
Paranoia (PAR)
Focuses on symptoms of paranoid disorders and on more enduring
characteristics of paranoid personality. Subscales include Resentment
(PAR-R), Hypervigilance (PAR-H), and Persecution (PAR-P).
Schizophrenia (SCZ)
Focuses on symptoms relevant to the broad spectrum of schizophrenic
disorders. Subscales include Psychotic Experiences (SCZ-P), Social
Detachment (SCZ-S), and Thought Disorder (SCZ-T).
Borderline Features (BOR)
Focuses on attributes indicative of a borderline level of personality
functioning, including unstable and fluctuating interpersonal relations,
impulsivity, affective lability and instability, and uncontrolled anger.
Subscales include Affective Instability (BOR-A), Identity Problems
(BOR-I), Negative Relationships (BOR-N), and Self-Harm (BOR-S).
Antisocial Features (ANT)
Focuses on history of illegal acts and authority problems, egocentrism,
lack of empathy and loyalty, instability, and excitement-seeking.
Subscales include Antisocial Behaviors (ANT-A), Egocentricity (ANTE), and Stimulus-Seeking (ANT-S).
Alcohol Problems (ALC)
Focuses on problematic consequences of alcohol use and features of
alcohol dependence.
Drug Problems (DRG)
Focuses on problematic consequences of drug use (both prescription
and illicit) and features of drug dependence.
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PAI Clinical, Treatment, and Interpersonal Scales (continued)
Scale
Treatment Scales
Aggression (AGG)

Suicidal Ideation (SUI)

Stress (STR)
Nonsupport (NON)
Treatment Rejection (RXR)

Interpersonal Scales
Dominance (DOM)

Warmth (WRM)

Description
Focuses on characteristics and attitudes related to anger, hostility, and
aggression, including a history of aggression (physical and verbal) and
attitudes conducive to aggressive behavior. Subscales include
Aggressive Attitude (AGG-A), Verbal Aggression (AGG-V), and
Physical Aggression (AGG-P).
Focuses on suicidal ideation, ranging from hopelessness through
general and vague thoughts of suicide to thoughts representing specific
plans for the suicidal act.
Focuses on the impact of current or recent stressors in areas of family,
health, employment, finances, and other major life areas.
Focuses on a lack of perceived social support, considering both the
level and quality of available support.
Focuses on attributes and attitudes theoretically predictive of interest
and motivation to make personal changes of a psychological or
emotional nature: a feeling of distress and dissatisfaction, willingness
to participate, recognition of need to change, openness to new ideas,
and a willingness to accept responsibility for actions.
Focuses on the extent to which a person is controlling and independent
in interpersonal relationships. Conceptualized as a bipolar dimension,
with a dominant style at the high end and a submissive interpersonal
style at the low end.
Focuses on the extent to which a person is supportive and empathic in
personal relationships. Conceptualized as a bipolar dimension, with a
warm, outgoing interpersonal style at the high end and a cold, rejecting
interpersonal style at the low end.

Note: Adapted from “Personality Assessment Inventory: Professional manual,” by L.C.
Morey, 1991, pp. 2-3, Odessa, FL: Psychological Assessment Resources.
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Appendix D
Diagnostic Consideration Clusters for MDD and GAD
_____
Relative
Relative
Disorder
Elevation
Suppression_
MDD

DEP-A
DEP-P
DEP-C
SUI
SCZ-T
SCZ-S

MAN-G

GAD

ANX
ANX-A

ARD
SCZ

_____
Note: Adapted from “PAI: Structural Summary-Revised,”
by L.C. Morey, 2007, Lutz, FL: Psychological Assessment
Resources.
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Mean PAI subscale elevations for the entire sample (N = 1541).
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Mean PAI subscale elevations for MDD (n = 135) and OD (n = 1327).
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Mean PAI subscale elevations for GAD (n = 79) and OD (n = 1327).
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Mean PAI subscale elevations for MDD (n = 135) and GAD (n = 79).
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Appendix F
Mean PAI Scale/Subscale Scores by Diagnostic Group and Entire Sample

PAI Scale/Subscale

__MDDa__
M
SD

__GADb__
M
SD

___ODc__
M
SD

__Totald__
M
SD

Inconsistency (ICN)
Infrequency (INF)
Negative Impression (NIM)
Positive Impression (PIM)
Somatic Complaints (SOM)
Anxiety (ANX)
Anxiety-Related Disorders (ARD)
Depression (DEP)
Mania (MAN)
Paranoia (PAR)
Schizophrenia (SCZ)
Borderline Features (BOR)
Antisocial Features (ANT)
Alcohol Problems (ALC)
Drug Problems (DRG)
Aggression (AGG)
Suicidal Ideation (SUI)
Stress (STR)
Nonsupport (NON)
Treatment Rejection (RXR)
Dominance (DOM)
Warmth (WRM)

52.04
50.79
57.49
39.15
53.33
63.47
56.87
74.04
49.82
56.37
61.21
65.59
52.12
50.19
50.56
52.40
64.20
58.66
60.67
36.27
45.43
45.66

48.96
52.44
51.75
40.54
52.84
75.80
59.20
62.00
50.56
52.65
55.33
57.89
47.73
48.30
48.67
49.91
52.16
54.20
52.47
39.28
44.65
47.04

50.71
52.17
55.04
41.49
52.30
64.41
57.27
64.07
52.64
55.12
57.99
61.89
53.04
50.63
49.73
51.71
54.87
56.87
56.47
40.30
47.07
47.60

50.74
52.07
55.08
41.23
52.42
64.91
57.33
64.83
52.29
55.10
58.14
62.01
52.69
50.48
49.75
51.68
55.55
56.89
56.63
39.89
46.80
47.40

7.13
7.91
10.31
9.55
8.21
11.68
12.29
13.16
9.45
11.22
12.20
10.21
9.12
9.87
11.54
10.53
18.28
10.62
12.49
8.81
10.65
11.89
98

6.44
8.30
8.66
9.81
8.26
10.78
10.14
10.96
9.04
10.85
10.31
10.24
7.73
8.35
11.71
10.11
14.47
9.01
11.23
9.10
11.46
9.43

7.57
7.97
10.31
10.57
9.85
13.91
13.16
14.01
11.21
11.69
12.50
11.96
11.04
11.05
12.47
11.71
14.08
11.21
12.79
10.46
11.65
11.57

7.49
7.99
10.28
10.46
9.64
13.82
12.95
14.09
11.00
11.62
12.41
11.82
10.79
10.84
12.35
11.54
14.76
11.08
12.77
10.32
11.57
11.50

Mean PAI Scale/Subscale Scores by Diagnostic Group and Entire Sample (continued)

PAI Scale/Subscale
Somatic Complaints
Conversion (SOM-C)
Somatization (SOM-S)
Health Concerns (SOM-H)
Anxiety
Cognitive (ANX-C)
Affective (ANX-A)
Physiological (ANX-P)
Anxiety-Related Disorders
Obsessive-Compulsive (ARD-O)
Phobias (ARD-P)
Traumatic Stress (ARD-T)
Depression
Cognitive (DEP-C)
Affective (DEP-A)
Physiological (DEP-P)
Mania
Activity Level (MAN-A)
Grandiosity (MAN-G)
Irritability (MAN-I)
Paranoia
Hypervigilance (PAR-H)
Persecution (PAR-P)
Resentment (PAR-R)

__MDDa__
M
SD

__GADb__
M
SD

___ODc__
M
SD

__Totald__
M
SD

50.00 7.34
57.04 11.18
51.41 8.85

50.67 8.66
55.42 10.31
51.04 7.99

50.64 10.15
54.36 10.98
50.89 10.02

50.59 9.86
54.65 10.99
50.94 9.82

64.79 12.05
60.72 12.27
60.62 12.26

76.92 8.95
71.22 10.51
71.09 14.95

64.88 13.34
61.71 13.60
62.17 14.34

65.49 13.31
62.11 13.51
62.49 14.34

49.14 11.63
53.99 10.62
61.08 15.42

53.81 10.56
59.92 10.60
56.27 13.30

51.74 12.43
54.14 11.62
59.35 14.70

51.62 12.30
54.43 11.55
59.34 14.71

73.43 14.17
74.49 13.14
63.60 12.31

61.97 13.44
59.08 11.48
59.58 10.65

63.80 15.01
63.85 14.91
58.31 11.83

64.55 15.11
64.53 14.95
58.84 11.90

51.89 10.57
46.36 10.78
52.09 10.84

52.48 10.72
47.63 9.40
52.13 10.55

53.41 11.83
49.63 10.87
53.66 11.87

53.23 11.67
49.25 10.83
53.44 11.72

57.66 13.66
50.29 9.60
57.69 11.06

54.00 11.91
48.70 9.57
53.81 10.54

57.08 13.30
50.45 9.89
55.14 11.33

56.98 13.28
50.34 9.85
55.29 11.29
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Mean PAI Scale/Subscale Scores by Diagnostic Group and Entire Sample (continued)

PAI Scale/Subscale
Schizophrenia
Psychotic Experiences (SCZ-P)
Social Detachment (SCZ-S)
Thought Disorder (SCZ-T)
Borderline Features
Affective Instability (BOR-A)
Identity Problems (BOR-I)
Negative Relationships (BOR-N)
Self-Harm (BOR-S)
Antisocial Features
Antisocial Behaviors (ANT-A)
Egocentricity (ANT-E)
Stimulus-Seeking (ANT-S)
Aggression
Aggressive Attitude (AGG-A)
Verbal Aggression (AGG-V)
Physical Aggression (AGG-P)

__MDDa__
M
SD

__GADb__
M
SD

___ODc__
M
SD

__Totald__
M
SD

49.01 10.25
59.08 13.34
66.12 15.18

45.76 7.15
53.09 11.28
62.32 12.81

48.72 10.39
54.83 12.93
63.80 15.12

48.59 10.25
55.12 12.94
63.92 15.03

62.59
67.96
62.51
55.25

56.63
59.19
58.33
49.56

59.46
63.30
60.09
53.93

59.58
63.50
60.21
53.82

11.05
10.97
11.39
12.06

12.18
9.78
11.49
8.62

12.89
11.96
12.20
12.41

12.75
11.88
12.12
12.25

50.62 9.91
49.52 8.96
54.85 10.87

46.86 7.71
48.44 7.52
49.47 9.38

51.05 10.42
52.18 10.39
54.59 12.33

50.80 10.29
51.76 10.20
54.35 12.12

50.68 12.81
49.45 10.51
51.33 11.42

49.70 12.18
48.19 12.44
48.59 8.32

49.59 12.64
49.45 12.08
50.36 11.14

49.69 12.63
49.38 11.96
50.35 11.04

Note: MDD = Major Depressive Disorder; GAD = Generalized Anxiety Disorder; OD = Other Diagnosis; Total = entire
sample.
a
n = 135. bn = 79. cn = 1327. dN = 1541.
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Appendix G
Percentage of Participants who matched Criteria for the Diagnostic
Consideration Clusters for MDD and GAD by Diagnostic Group
PAI Scale/
Subscale

MDDa

GADb

____
ODc

MDD DCCd
DEP-Ae
DEP-Pe
DEP-Ce
SUIe
SCZ-Te
SCZ-Se
MAN-Gf

2.2%
83.7%
48.1%
80.7%
45.2%
56.3%
37.8%
70.4%

0%
43.0%
50.6%
45.6%
16.5%
54.4%
22.8%
64.6%

0.8%
54.0%
37.8%
54.6%
21.6%
53.1%
27.1%
55.1%

GAD DCCd
ANXe
ANX-Ae
ARDf
SCZf

3.7%
52.6%
44.4%
34.1%
18.5%

3.8%
93.7%
83.5%
15.2%
26.6%

1.2%
58.6%
49.0%
26.8%
21.9%

Group

Note: DCC = Diagnostic Consideration Cluster; MDD = Major Depressive
Disorder; GAD = Generalized Anxiety Disorder; OD = Other Diagnosis.
a
n = 135. bn = 79. cn = 1327. dAll Scales/Subscales of the DCC.
e
Relative Elevation. fRelative Suppression.
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Appendix H
Standardized Coefficients and Correlations of the Significant PAI Scales/Subscales with
the Discriminant Function for MDD and OD

Predictor
DEP
SUI
ANT-E
ANX

Correlation coefficients
with discriminant function
.649
.583
-.235
-.062

Standardized coefficients
for discriminant function
0.992
0.391
-0.330
-0.810

Note: Pooled within-groups correlations between discriminating variables and
standardized canonical discriminant function. Variables ordered by absolute size of
correlation within function.
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Appendix I
Standardized Coefficients and Correlations of the Significant PAI Scales/Subscales with
the Discriminant Function for GAD and OD

Predictor
ANX-C
BOR-I
DEP-A

Correlation coefficients
with discriminant function
.630
-.238
-.222

Standardized coefficients
for discriminant function
1.197
-0.596
-0.466

Note: Pooled within-groups correlations between discriminating variables and
standardized canonical discriminant function. Variables ordered by absolute size of
correlation within function.
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Appendix J
Standardized Coefficients and Correlations of the Significant PAI Scales/Subscales with
the Discriminant Function for MDD and GAD

Predictor
DEP-A
ANX
BOR-S
SCZ-P
SOM-S
MAN-G

Correlation coefficients
with discriminant function
.498
-.440
.211
.143
.061
-.050

Standardized coefficients
for discriminant function
0.707
-1.139
0.391
0.267
0.252
-0.217

Note: Pooled within-groups correlations between discriminating variables and
standardized canonical discriminant function. Variables ordered by absolute size of
correlation within function.
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Appendix K
Proposed Diagnostic Consideration Clusters for MDD
and GAD with University Counseling Center Clients
_____
Relative
Relative
Disorder
Elevation
Suppression_
MDD

DEP-A c
DEPc
DEP-Cd
MAN-Ge
BOR-I
BORg

GAD

f

SCZ-Pg
ANT-Eg
SOM-Cg
ARD-Og
MANg

ANX-Ca
ANXb
ANX-Ac
ANX-Pd
SCZ-Pe
ANT-Af
ANTg
MAN-Gg
ANT-Eg
ALCg
_____

Note: MDD = Major Depressive Disorder;
GAD = Generalized Anxiety Disorder.
a
hit rate >= 95%. b 90% <= hit rate < 95%.
c
80% <= hit rate < 85%. d 75% <= hit rate < 80%.
e
70% <= hit rate < 75%. f 65% <= hit rate < 70%.
g
60% <= hit rate < 65%.
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